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Although polyamines were originally 
discovered during the XVIIth century, 
their importance for the organism 
is still not completely understood. 
The use of molecules that resemble 
polyamines in their structure and 
function, i.e. polyamine analogues, 
and transgenic mice are the most 
used tools for the study of polyamines 
and their metabolism. The original 
techniques used for the analysis of 
polyamine functions and metabolism 
present limitations. Therefore, the 
development of new techniques to be 
used in the polyamine metabolism 
research could provide the necessary 
tools to advance our knowledge in this 
field.
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ABSTRACT
Polyamines are a group of naturally occurring molecules that contain two or more amino
groups. In eukaryotes, polyamine metabolism is tightly controlled at both the synthetic
and catabolic pathways. The rate limiting enzymes for the polyamine metabolism are
ornithine decarboxylase (ODC) in the synthetic pathway and spermidine/spermine
N1-acetyltransferase (SSAT) in catabolism. Polyamines are involved in a wide range of
cellular functions, and due to their positive charge, they can interact with many
negatively charged cellular components, such as proteins, phospholipids or DNA. This
wide range of polyamines functions means that alterations in their normal levels have
been linked with many different diseases, such as obesity and diabetes, cancer, and
pancreatitis.
The use of polyamine analogues to investigate the polyamine metabolism is
common practice. However, in vivo studies require larger amounts of the
?-methylated-polyamine analogues than the current production methods can supply.
Therefore, an improved synthetic method for ?-methylated-polyamines was developed,
allowing for increased production yields and the in vivo testing of these analogues.
In mice, the overexpression of the SSAT gene when it is placed under the control
of a metallothionein I heavy metal inducible promoter (MT-SSAT) produces bizarre
phenotypic changes. The acute SSAT activation offers a model to investigate
physiological changes produced by altering the polyamine catabolism, and could
produce new information regarding the polyamine metabolism.
The proteomic profiling of the MT-SSAT livers demonstrated that most of the
altered protein expressions were directly related to the activation of polyamine
catabolism. Some of the altered proteins were regulated by peroxisome
proliferator-activated receptor ? co-activator 1? (PGC 1?). Moreover, the MT-SSAT mice
exhibited improved insulin sensitivity and glucose tolerance when compared with their
non-transgenic littermates. ATP levels were much lower in the transgenic mice due to the
constant activation of the polyamine cycle, which consumes four ATP equivalents per
turn. The decreased energy levels activated PGC 1?. Moreover, the continuous activation
of  polyamine  catabolism,  such  as  seen  in  the  MT-SSAT  mice,  was  accompanied  by
increased oxidative stress. Consequently, the transcription factor p53 appeared activated
in  the  transgenic  mice.  The  acute  activation  of  p53  was  responsible  for  the  accelerated
aging of the MT-SSAT mice.
National Library of Medicine Classification: QU 61, QU 135, QY 60.R6
Medical Subject Headings (MeSH): Acetyltransferases; Chromatography, Liquid; Energy
Metabolism; Enzymes; Liver/metabolism; Mice; Mice, Transgenic; Oxidative Stress;
Polyamines/metabolism; Proteomics; Tandem Mass Spectrometry
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TIIVISTELMÄ
Polyamiinit ovat ryhmä luontaisesti esiintyviä molekyylejä, joissa on yksi tai useampi
aminoryhmä. Eukaryooteissa polyamiiniaineenvaihdunnan reitit ovat tiukasti säädeltyjä
sekä synteesin että katabolian osalta. Polyamiinien synteesireitin rajoittava entsyymi on
ornitiinidekarboksylaasi (ODC) ja hajotusreitin puolestaan spermidiini/spermiini
N1-asetyylitransferaasi (SSAT). Polyamiinit osallistuvat lukuisiin erilaisiin solun
toimintoihin, ja positiivisen varauksensa vuoksi ne ovat vuorovaikutuksessa monien
negatiivisesti varautuneiden solun rakenneosien, kuten proteiinien, fosfolipidien ja
DNA:n kanssa. Koska polyamiinit osallistuvat niin moninaisiin solun toimintoihin,
niiden pitoisuuksissa tapahtuvien muutosten on todettu olevan yhteydessä monenlaisiin
tauteihin, kuten ylipainoon ja diabetekseen, syöpään ja haimatulehdukseen.
Polyamiinianalogeja käytetään yleisesti polyamiiniaineenvaihdunnan tutkimuksessa.
Kuitenkin in vivo-tutkimukset vaativat suurempia määriä ?-metyloituja
polyamiinianalogeja kuin nykyisillä menetelmillä saadaan tuotettua. Sen vuoksi
kehitimme entistä paremman menetelmän ?-metyloitujen polyamiinianalogien
tuottamiseen, mikä mahdollistaa niiden riittävän saannon in vivo-kokeita varten.
Siirtogeenisissä hiirissä SSAT-geenin ilmentyminen raskasmetalleilla aktivoituvan
metallotioneiini I-promoottorin alaisuudessa (MT-SSAT) tuottaa erityislaatuisia
muutoksia hiiren ilmiasuun. Akuutti SSAT-aktivaatio tarjoaa mallin, jolla voidaan tutkia,
millaisia fysiologisia muutoksia polyamiinien hajotusreitin muutokset aiheuttavat, ja
tarjoaa uutta tietoa polyamiiniaineenvaihdunnan merkityksestä.
MT-SSAT-hiirten proteominen profilointi osoitti, että useimmat muutokset
proteiinien ilmentymisessä olivat suoraan yhteydessä polyamiinikatabolian aktivaatioon.
Osa proteiineista oli sellaisia, joita säätelee peroksisomiproliferaattori-aktivoituvan
reseptori gamman ko-aktivaattori 1? (PGC 1?). Lisäksi MT-SSAT-hiiret olivat
insuliiniherkempiä ja niillä oli lisääntynyt glukoosinsietokyky ei-siirtogeenisiin
verrokkihiiriin nähden. Siirtogeenisillä hiirillä oli myös kudoksissa alentuneet
ATP-pitoisuudet, mikä johtuu jatkuvasti aktivoituneesta polyamiinien hajotussyklistä,
joka kuluttaa energiaa neljä ATP-ekvivalenttia kierrosta kohti. Vähentynyt energiamäärä
soluissa aktivoi PGC 1?:a. Lisäksi MT-SSAT -hiirten jatkuva polyamiinikatabolian
aktivaatio johti niissä lisääntyneeseen oksidatiiviseen stressiin. Tämän seurauksena
transkriptiofaktori p53 oli siirtogeenisissä hiirissä aktivoitunut. Akuutti p53:n aktivaatio
MT-SSAT hiirissä johti nopeutuneeseen vanhenemiseen.
Yleinen suomalainen asiasanasto: aineenvaihdunta, entsyymit, polyamiinit, hiiret,
solufysiologia, vanheminen
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 1 Introduction
Polyamines are a family of organic compounds whose chemical structure
is  based  on  a  carbon  backbone  chain  with  two  or  more  nitrogen  heteroatoms,
thus the name polyamine. Polyamines are encountered in all living organisms,
from prokaryotes to eukaryotes, although one exception does exist, two orders
of Archaea, the Methanobacteriales and the Halobacteriales,  do  not  contain
polyamines in their cells (Hamana et al., 1992). In the higher eukaryotes, the
term polyamine is commonly used to refer to the diamine
putrescine (1,4-diaminobuthane (Figure 1 compound (1)), the triamine
spermidine (N-(3-aminopropyl)butane-1,4-diamine (Figure 1 compound (2)), the
tetraamine spermine (N,N'-bis(3-aminopropyl)butane-1,4-diamine (Figure 1
compound (3)), and their acetylated derivates. Eukaryotic cells only synthesize
linear polyamines. However, lower organisms such as Eubacteria, Archaebacteria,
or Cyanobacteria, produce polyamines with more complicated structures, such as
branched polyamines (Hamana et al., 1992).
In  the  year  1678,  “The  Father  of  Microbiology”,  Antonie  P.  van
Leeuwenhoek, after isolating crystals of spermine phosphate from human
semen, described for the first time a polyamine (van Leeuwenhoek 1678). It was
two hundred years later before Brieger identified putrescine (1885). The
common names of the different polyamines are derived from the original source
used for their isolation. Human semen was the original source for spermine and
spermidine, whereas putrescine was isolated from putrefying flesh.
More than 330 years after polyamines were first isolated (van
Leeuwenhoek 1678), and more than 80 years after their modern re-discovery by
Dudley et al (1924), their exact functions still remain a mystery. The presence of
the amino groups in the polyamine structure makes them positively charged at
physiological pH, and this particular characteristic allows polyamines to
substitute for inorganic cations, such as magnesium or calcium in cellular
physiology.  Moreover,  the  fact  that  the positive  charges  are  not  equally  spaced
along the carbon backbone extends the versatility of these molecules over that of
simple inorganic cations (Jänne et al., 2004). The combination of these features,
positive and differentially spaced charges, means that polyamines can interact
with negatively charged bio-molecules, such as phospholipids, DNA and
RNA (Jänne et al., 2004). This interaction between the polyamines and the
various biomolecules is probably the basis of their biological functions. The
intracellular concentrations of polyamines are at the millimolar level. However,
most  of  the  polyamines  are  expected  to  be  bound  by  ionic  interactions  to
2different cell components, and therefore, the amount of free polyamines is
anticipated to be much lower (Jänne et al., 2004).
Figure 1. Chemical structures of: (1) putrescine (1,4-diaminobuthane), (2)
spermidine (N-(3-aminopropyl)butane-1,4-diamine), and (3) spermine
(N,N'-bis(3-aminopropyl)butane-1,4-diamine).
A useful approach for elucidating polyamine metabolism and obtain
knowledge  of  their  functions  is  to  study  transgenic  animals  either
overexpressing or deficient in the polyamine metabolizing enzymes (Jänne et al.,
2004; Jänne et al., 2005). Accordingly, the present study has taken advantage of
different genetically modified mouse lines to expand the roles of polyamines in
physiology and pathology. Most of the work was undertaken using a transgenic
mouse  line  that  expresses  the  SSAT  genes  under  the  control  of  a  heavy  metal
inducible promoter (MT-SSAT (UKU 181F)) (Suppola et al., 1999), but also a
mouse line overexpressing SSAT under its natural promoter (SSAT (UKU
165F) (Pietilä et al., 1997), and a mouse line with disrupted SSAT
expression (SSATKO (KI1)) (Niiranen et al., 2006) were used.
The present study can be divided into three differentiated sections:
? One, the study of the effects of alpha-methylated polyamine analogues
on the MT-SSAT transgenic mice. These mice are a useful model for the
study of how rationally developed polyamine analogues affect polyamine
metabolism and functionality. The activated polyamine catabolism in the
MT-SSAT mice, which depleted the natural polyamines, made it possible to
analyze whether the analogues were able to substitute the depleted
polyamines and whether these analogues could be metabolized
? Two, application of new techniques in polyamine research, such as
LC-MS/MS polyamine analysis. The recent recognition of polyamine flux as
the cause of some metabolic disorders (Pirinen et al., 2007; Jell et al., 2007)
has resurrected the interest in these compounds. These newly designed
protocols  for  the  study  of  polyamines  allowed  overcoming  some  of  the
limitations of previous methodologies
? Three, detailed characterization of the metabolic effects of activated
polyamine flux in the MT-SSAT transgenic mice. The analysis of the SSAT
transgenic mice has been performed in previous studies (Pirinen et al., 2007;
3Pirinen  et  al.,  2009).  These  studies  demonstrated  that  activation  of
polyamine flux could affect many other metabolic pathways, such as insulin
secretion, cholesterol and bile acid synthesis. Thus, the effects on the liver of
activated polyamine catabolism, the causes of accelerated aging, and the
altered insulin secretion were studied in detail
4 2 Review of the literature
 2.1 POLYAMINES AND THEIR METABOLISM
Polyamines are actively produced in all mammalian cells, but are present at
especially high levels in the liver, pancreas, and testes (Rosenthal and Tabor,
1956). One basic difference between eukaryotic and prokaryotic cells, according
to their polyamine metabolism, is the absence of the spermine synthase gene
and, thus, spermine can only by synthesized in the latter group only (Heby,
1981). Cellular polyamine levels are tightly controlled by the combined
regulation of their metabolism (Figure 2) and transport (uptake and excretion).
 2.2 Polyamine biosynthesis
In the higher eukaryotes, polyamines originate from two amino acids, L-arginine
and L-methionine. During the urea cycle, L-arginine is converted into urea by
arginase I in the liver (ARGI1) or arginase II in extrahepatic tissues (ARGI2).
L-Ornithine is formed as a by-product of the arginase reaction. L-Ornithine can
then either be cycled back into the urea cycle as citrulline, or used in polyamine
metabolism. During polyamine metabolism, L-ornithine is decarboxylated by
ornithine decarboxylase (ODC), a reaction that produces putrescine. This
reaction is considered as the first rate-limiting step in polyamine biosynthesis.
In non-mammalian organisms, putrescine may be synthesized via an
alternative pathway that involves the production of agmatine through the
decarboxylation of L-arginine by arginine decarboxylase (ADC). Agmatine is
then further hydrolyzed by agmatinase (AUH) to yield putrescine. Some recent
evidence pointed to the presence of an agmatinase gene in the mouse and
human genomes (Agmat and AGMAT) (Iyer et al., 2002). However, Coleman et
al (2004) were unsuccessful in reproducing the original experiments, which had
claimed to identify the existence of a mammalian ADC (Lortie et al., 1996;
Regunathan et al., 2000). Thus, evidence for a mammalian ADC enzyme is still
inconclusive.  However,  even  though  there  is  no  proven  evidence  for  a
mammalian ADC ortholog, this pathway should not be totally eliminated as a
possible source of putrescine because agmatine, which is an essential bacterial
5and plant component, could be obtained from the diet.
The second amino acid precursor in polyamine biosynthesis is the
essential amino acid L-methionine. Before L-methionine can be utilized in the
polyamine biosynthesis, it needs to be converted into decarboxylated
S-adenosyl-L-methionine (dcAdoMet) by a two-step reaction. In the first
reaction, the enzyme methionine adenosyltransferase (MAT1) transforms
L-methionine into S-adenosyl-L-methionine (AdoMet). The second reaction
involves the decarboxylation of AdoMet into dcAdoMet by
S-adenosyl-L-methionine decarboxylase (AdoMetDC). AdoMet is a common
substrate for many different methylation reactions, in fact, only about 5% of the
total available AdoMet is decarboxylated and committed for polyamine
biosynthesis (Mudd and Poole, 1975). The enzymatic reaction producing
dcAdoMet is regarded as the second rate-limiting step of the polyamine
biosynthesis.
The higher polyamines, spermidine and spermine, are formed by the
combination of putrescine and dcAdoMet. Spermidine synthase (SPDSY)
catalyzes the combination of the diamine putrescine and an aminopropyl group
from dcAdoMet. The triamine, spermidine, is then used for the production of
spermine by the addition of a second aminopropyl group also provided by
dcAdoMet. The spermine synthesis is catalyzed by spermine synthase (SPSY).
The syntheses of spermidine and spermine produce the highly toxic
5´-methylthioadenosine (MTA) as a by-product that is salvaged back into
L-methionine and adenosine (Ávila et al., 2004).
6Figure 2. Schematic overview of polyamine metabolism in higher eukaryotes.
The polyamine precursors are the amino acids L-ornithine, produced in the urea cycle,
and L-methionine. L-ornithine is decarboxylated by ornithine decarboxylase (ODC) to
produce the diamine, putrescine. L -methionine is first transformed into
S-adenosyl-L-methionine (AdoMet) by methionine adenosyltransferase (MAT1), and it
is further decarboxylated by S-adenosyl-L-methionine decarboxylase (AdoMetDC)
yielding decarboxylated S-adenosyl-L-methionine (dcAdoMet). dcAdoMet is used by
spermidine synthase (SPDSY) and spermine synthase (SPSY) to produce spermidine
and spermine. Spermidine and spermine catabolism (upper scheme) is a two-step
reaction in which spermine or spermidine is first acetylated by spermidine/spermine
N1-acetyltransferase (SSAT) and then oxidized by polyamine oxidase (APAO) to
produce spermidine or putrescine, respectively. Spermine can also be directly
backconverted into spermidine by spermine oxidase (SMO) omitting the acetylation
step. Lines with arrows indicate the reaction direction  (??), lines with squares indicate
repression (??). OAZ, antizyme; AZI, antizyme inhibitor; MTA,
5’-methylthioadenosine; eIF-5a, eukaryotic initiation factor 5a.
7Table 1. List of all proteins related with the polyamine metabolism.
Protein name Abbreviation EC Organism Gene GeneID Uniprot
Agmatinase AUH 3.5.3.11
H. sapiens AGMAT 79814 Q9BSE5
M. musculus Agmat 75986 A2AS89
Aldehyde
dehydrogenase
ALDH 1.2.1.5
H. sapiens ALDH 216 P00352
M. musculus Aldh 11668 P24549
Antizyme OAZ ND
H. sapiens OAZ1 4946 P54368
M. musculus Oaz1 18245 P54369
Antizyme inhibitor AZI ND
H. sapiens AZIN1 51582 O14977
M. musculus Azin1 54375 O35484
Arginase I ARGI1 3.5.3.1
H. sapiens ARG1 383 P05089
M. musculus Arg1 11846 Q61176
Arginase II ARGI2 3.5.3.1
H. sapiens ARG2 384 P78540
M. musculus Arg2 11847 O08691
Arginine
decarboxylase
ADC 4.1.1.19
H. sapiens ADC 113451 Q96A70
M. musculus Adc 242669 B2RSR5
Catalase CAT 1.11.1.6
H. sapiens CAT 847 P04040
M. musculus Cat 12359 P24270
Deoxyhypusine
hydroxylase
DOHH 1.14.99.29
H. sapiens DOHH 83475 Q9BU89
M. musculus Dohh 102115 Q99LN9
Deoxyhypusine
synthase
DHS 2.5.1.46
H. sapiens DHPS 1725 P49366
M. musculus Dhps 330817 Q3TXU5
Eukaryotic initiation
factor 5a
eIF-5a ND
H. sapiens EIF5A 1984 P63241
M. musculus Eif5a 276770 P63242
Ornithine
decarboxylase
ODC 4.1.1.17
H. sapiens ODC1 4953 P11926
M. musculus Odc1 18263 P00860
Polyamine oxidase APAO 1.5.3.11
H. sapiens PAOX 196743 Q6QHF9
M. musculus Paox 212503 Q8C0L6
Methionine
adenosyltransferase
MAT1 2.5.1.6
H. sapiens MAT1A 4143 Q00266
M. musculus Mat1a 11720 Q91X83
NAD(P)H quinone
oxidoreductase
QR1 1.6.5.2
H. sapiens NQO1 1728 P15559
M. musculus Nqo1 18104 Q64669
S-adenosyl-L-methioni
ne decarboxylase
AdoMetDC 4.1.1.50
H. sapiens AMD1 262 P17707
M. musculus Amd1 11702 P31154
Spermidine/spermine
N1-acetyltransferase
SSAT 2.3.1.57
H. sapiens SAT1 6303 P21673
M. musculus Sat1 20229 P48026
Spermidine synthase SPDSY 2.5.1.16
H. sapiens SMS 6611 P52788
M. musculus Sms 20810 Q64674
Spermine oxidase SMO 1.5.3.16
H. sapiens SMOX 54498 Q9NWM0
M. musculus Smox 228608 Q99K82
Spermine synthase SPSY 2.5.1.22
H. sapiens SRM 6723 P19623
M. musculus Srm 20603 P97355
The column abbreviation corresponds with the abbreviation used in the text.
The E.C. column displays the enzyme classification code for the given protein. ND, not disponible.
The gene column shows the name of the gene that encodes the protein.
The GeneID column shows the correspondent code for the given gene in the Entrez Gene database,
while the Uniprot column shows the code for the protein in the Uniprot database.
8 2.2.1 Regulation of polyamine biosynthesis
There are six different reactions in polyamine biosynthesis pathway but two of
them have been considered as rate-limiting. The two rate-limiting reactions are
the ones catalyzed by ODC (decarboxylation of L-ornithine to putrescine), and
AdoMetDC (production of dcAdoMet).
 2.2.1.1 ODC regulation
The murine ornithine decarboxylase gene spans a total of 3453 bp, and contains
a total of ten exons that transcribe into a 1386 bp long mRNA, the end product
of which is a 461 amino acid long protein with a mass of 51.1 kDa.
ODC is controlled at all phases of its synthesis, from the transcription to
posttranslational stages. At the transcription level, the human ODC gene
contains multiple regulatory elements, including GC-boxes, cAMP response
elements (CRE), AP-1 and AP-2 motifs, a TATA box, a CAAT site, a putative
insulin response element, and several Sp1 binding sites (Qin et al., 2004; Shantz
and Pegg, 1999; Manzella et al., 1991). Moreover, the Odc promoter region
contains two E boxes containing the canonical sequence for Myc/Max
transcription factor binding (CACGTG) (Packham and Cleveland, 1997). The
Odc gene is also regulated at the translational level. Odc mRNA contains a long
5’-UTR with a predicted complex secondary structure hindering its efficient
translation. Thus, translation initiation factors, such as eukaryotic initiation
factor 4E (eIF-4E), can improve the translation efficiency (Shantz and Pegg,
1994).
The ODC enzyme functions as a pyridoxal 5´-phosphate dependent
decarboxylase.  The  active  form  of  ODC  is  a  homodimer  containing  two  active
sites at the interface of the two monomers (Coleman et al., 1994). Under normal
conditions, ODC has a half-life of less than one hour (Shantz and Pegg, 1999).
The  enzyme  is  tightly  regulated  at  the  posttranscriptional  level  through  a
protein  that  shares  a  high  similarity  with  ODC  and  named
antizyme (OAZ) (Heller et al., 1976; Murakami et al., 1992). OAZ is a conserved
protein among all eukaryotes, from yeast to man. There are three different OAZ
isoforms. OAZ1 and OAZ2 are expressed in most vertebrate tissues, with OAZ2
being expressed at a much lower level than the other forms (Coffino 2001).
OAZ3  expression  is  limited  to  the  testis  during  the  late  sperm
morphogenesis (Ivanov et al., 2000). OAZ plays a dual role in reducing the
intracellular polyamine content. First, OAZ acts by binding to the ODC
monomer,  with  higher  affinity  than  ODC  itself.  The  formation  of  the
heterodimer, ODC-OAZ, has two consequences, first inactivation of ODC and
second, OAZ targets ODC for degradation for the 26S proteasome in an
9ubiquitin-independent manner (Kahana 2007). The interaction between ODC
and OAZ produces a change of conformation in the ODC protein exposing the
last  37  amino  acids  from  the  C-terminus  that  are  used  as  a  signal  by  the  26S
proteasome (Li et al., 1993). Once ODC is presented into the 26S proteasome,
OAZ is released and able to recruit new ODC monomers (Gandre et al., 2002).
OAZ1 and OAZ2 differ in the way that they regulate ODC. OAZ2 is not able to
induce  ODC  proteasomal  degradation,  instead  it  sequesters  the  ODC
monomers, thus inhibiting the ODC enzymatic activity (Zhu et al., 1999). ODC
inactivation  by  OAZ  reduces  its  enzymatic  activity  as  well  as  the  uptake  of
extracellular polyamines.
OAZ itself possesses a unique translational regulation mechanism that is
polyamine mediated. When cellular polyamine levels are elevated and
polyamine biosynthesis needs to be inhibited, polyamines induce a translational
+1 ORF frameshifting in the Oaz mRNA. The ribosomal frameshift allows for
translation of the Oaz mRNA into its functional form (Matsufuji et al., 1995).
The  third  player  in  ODC  regulation  is  a  protein  named  antizyme
inhibitor (AZI) (Fujita et al., 1982). There are two different forms of the AZI
protein. AZI2 is an ODC paralogue (Pitkänen et al., 2001). AZI1 is ubiquitously
expressed, whereas AZI2 expression is limited to the testis, brain and mast
cells (Pitkänen et al., 2001; López-Contreras et al., 2006; Kanerva et al., 2009).
AZI  structures  are  very  similar  to  ODC,  but  they  lack  any  decarboxylase
activity (Murakami et al., 1996). AZIs have a higher affinity for OAZ than does
ODC itself. Therefore, the heterodimers formed between AZI and OAZ are
stronger than those between ODC and OAZ (Fujita et al., 1982). AZIs stabilize
the ODC homodimers prolonging their half-life (Mangold, 2005). Both,
AZIs  (Bercovich et  al.,  2004)  and OAZ are  degraded in an ubiquitin-dependent
manner (Gandre et al., 2002). Interestingly, the interaction between OAZ and
AZIs promotes the stabilization of both proteins, the opposite of the situation
with the heterodimer ODC-OAZ. Recently, an alternative pathway of ODC
degradation has been described (Asher et al., 2005). In this secondary pathway,
ODC  degradation  occurs  through  the  20S  proteasome,  and  is  regulated  by  the
enzyme NAD(P)H quinone oxidoreductase (QR1).
 2.2.1.2 AdoMetDC regulation
The mouse AdoMetDC gene spans a total of 12530 bp, and contains eight exons
that are transcribed into a 1005 bp long mRNA. The mRNA is translated into a
334 amino acid long proenzyme with a mass of 38.3 kDa. The proenzyme is
autocatalytically cleaved to form the ? (30.7 kDa) and ? subunits (7.7 kDa), and
the pyruvoyl cofactor (Stanley et al., 1989).
Similarly to ODC, AdoMetDC presents a long 5’-UTR with a predicted
complex  secondary  structure.  Included  in  the  AdoMetDC  5’-UTR  there  is  a  15
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nucleotides-long small upstream ORF (uORF) (Shantz et al., 1994) that is
believed to be responsible for the translational regulation by polyamines (Hill
and Morris, 1992; Ruan et al., 1996). Putrescine enhances the conversion of the
proenzyme  to  the  active  form  (Pegg  et  al.,  1988),  and  also  produces  a
conformational change in the active protein lowering its Km for  the
substrate (Pegg and Williams-Ashman, 1969). Moreover, MTA, a by-product
produced during spermine and spermidine biosynthesis, negatively regulates
AdoMetDC activity. However, since 5´-methylthioadenosine (MTA) is rapidly
recycled into methionine and adenosine, it has been suggested that this control
mechanism is  not  very relevant  (Bachrach et  al.,  1989).  AdoMetDC is  degraded
in  an  ubiquitin-dependent  manner  (Yerlikaya  and  Stanley,  2004).  In  humans,  it
has been estimated that the majority of AdoMet serves as a methyl donor in
diverse methylation reactions, and only 5 % of the total is decarboxylated and
destined to be used as an aminopropyl donor in polyamine biosynthesis (Mudd
and Poole, 1975).
 2.3 POLYAMINE CATABOLISM
Polyamine biosynthesis and catabolism are directly interconnected, meaning
that all polyamines are interconversible. There are two pathways involved in
polyamine catabolism. The main catabolic pathway is the acetylation pathway
that  involves  a  two-step  reaction.  In  the  first  step,  spermine  or  spermidine  are
acetylated by spermidine/spermine N1-acetyltransferase (SSAT), acetyl-CoA acts
as  the  donor  of  the  acetyl  group  in  this  reaction  (Hölttä  et  al.,  1973).  In  the
second step, polyamine oxidase (APAO) removes the aminpropyl group from
the N-acetylated  spermine  or N-acetylated spermidine, producing hydrogen
peroxide and an aldehyde, 3-acetaminopropanal, and transforming the original
input polyamines into spermidine or putrescine, respectively (Bolkenius and
Seiler, 1981). From the two by-products, hydrogen peroxide is converted into
water and oxygen by catalase (CAT). The second by-product,
3-acetaminopropanal can be either detoxified by aldehyde
dehydrogenase (ALDH) into N-acetyl-?-alanine or spontaneously converted into
the highly reactive acrolein by beta elimination. N-acetyl-?-alanine is further
metabolized by a coupled reaction of deacetylation-transamination (Seiler 2004),
The second catabolic pathway involves the direct oxidation of spermine
into spermidine by the spermine oxidase enzyme (SMO). This reaction occurs
without the need for prior acetylation of the spermine substrate (Vujcic et al.,
2002a). The SMO catalyzed reaction produces two by-products, hydrogen
peroxide and 3-aminopropanal, which are detoxified by the same combination
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of enzymes as the by-products of the acetylation pathway.
 2.3.1 Regulation of polyamine catabolism
 2.3.1.1 SSAT regulation
The  SSAT  gene  is  located  in  the  X  chromosome  and  is  encoded  by  a  2672  bp
sequence divided into six exons. The Sat1 gene  transcribes  into  a  516  bp  long
mRNA that translates into a 171 amino acid long protein with a mass of 20 kDa.
The SSAT enzyme belongs to the general control nonderepressible 5 (GCN5)
N-acetyltransferase family.  SSAT  functions  as  a  homodimer  providing  two
active sites. This enzyme catalyzes the acetylation of the polyamines, spermidine
and  spermine,  by  adding  an  acetyl  group  provided  by  acetyl-CoA.  The
acetylation of polyamines is a required step for their further oxidation by APAO.
SSAT was originally discovered as a greatly inducible enzyme that accumulated
in rodent liver after treatment with carbon tetrachloride (Hölttä et al., 1973).
Similarly to ODC, SSAT expression is controlled at the transcriptional, mRNA
processing, translational and post-translational levels.
The human SAT1 promoter lacks the TATAA or CCAAT boxes. However,
it has many potential binding sites for Sp-1, AP-1, E2F, AP2, PEA-3 (Fogel-
Petrovic et al., 1993), CCAT/enhancer binding protein-? (C/EBP?), CREB, NF-??,
and peroxisome proliferator activated receptors (PPARs) (Fogel-Petrovic et al.,
1993; Choi et al., 2006; Babbar et al., 2003). The Sat1 is transcriptionally regulated
by a polyamine response element (PRE) located at -1522 bp before the gene
transcription start site (5´-TATGACTAA-3´) (Wang et al., 1998). Under
conditions  of  high  polyamine  loads,  the  PRE  interacts  with  the  transcription
factor NF-E2-related factor 2 (Nrf-2) and then recruits the polyamine-modulated
factor 1 (PMF 1) that activates SSAT transcription (Wang et al., 2001a).
The Sat1 mRNA is controlled by alternative splicing. Thus, when high
levels of polyamines are present, enhanced catabolism is needed and the
original mRNA splices into the form encoding for the catalytically functional
SSAT.  However,  when  polyamine  levels  are  low,  an  extra  110bp  exon  is
transcribed between exons three and four, producing the SSAT-X mRNA variant.
This extra exon contains multiple premature termination codons that, if
translated, would produce a truncated SSAT version of only 71 amino acids. The
SSAT-X mRNA is rapidly targeted to the nonsense mediated mRNA decay
pathway (Hyvönen et al., 2006). Moreover, Sat1 mRNA translation is regulated
by  an  unknown  inhibitory  protein  that  associates  with  the  coding  part  of  the
mRNA. Under high polyamine levels, this unknown protein dissociates from
the  SSAT  mRNA,  meaning  that  translation  can  proceed  (Fogel-Petrovic  et  al.,
1996; Butcher et al., 2007).
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The SSAT activity is usually very low in normal cells, and its half-life is
very  short,  being  less  than  15  minutes  in  the  rat  liver  after  thioacetamide
treatment (Matsui and Pegg, 1981; Persson and Pegg, 1984). SSAT is degraded by
the 26S proteasome after polyubiquitination. SSAT turnover requires the
presence  of  a  MATEE  sequence  found  in  its  carboxyl  terminal  (Coleman  and
Pegg,  1997).  The  association  of  polyamines  or  their  analogues  with  the  SSAT
protein can extend its half-life by preventing its ubiquitination to more than 12
hours (Fogel-Petrovic et al., 1996; McCloskey and Pegg, 2000).
 2.3.1.2 APAO regulation
The APAO gene spans 8428 bp and contains  seven exons that  transcribe into a
1515 bp-long mRNA that codes for a 504 amino acid long protein with an
estimated  mass  of  55.4  KDa.  APAO  was  first  purified  from  rat  liver  in  the  late
70’s by Hölttä (1977). APAO is a flavin adenine dinucleotide-dependent amine
oxidase that preferentially oxidizes mono and di-acetylated polyamines and, to
a lesser extent, spermine. However, it does not react with spermidine (relative
reactivity: N1-acetylspermine > N1,N12-diacetylspermine > N1-acetylspermidine
>> spermine) (Seiler, 1995; Bolkenius and Seiler, 1981). The APAO reaction
produces two by-products, hydrogen peroxide and 3-acetaminopropanal. APAO
is widely distributed in all vertebrate tissues and localizes in the cytoplasm and
the peroxisomes (Hölttä, 1977). Acetylated polyamines are either catabolized by
APAO or efficiently excreted out of the cells. This is the reason why acetylated
polyamines are rarely detected in biological samples, unless there is acute SSAT
activation (Casero and Pegg, 1993).
 2.3.1.3 SMO regulation
The murine SMO coding region spans 32230 bp, the murine gene contains six
exons (eight in the human gene) that create an mRNA of 1668 bp. The final
protein has a length of 555 amino acids and a mass of 61.8 kDa. SMO was
recently  discovered  by  Wang  et  al  (2001b),  making  it  the  latest  enzyme  to  be
incorporated  into  the  known  scheme  of  the  polyamine  metabolism.  SMO  was
originally  named  PAOh1,  since  it  was  the  first  human  PAO  to  be  cloned.
Subsequently, the name was changed to SMO after confirmation that this
particular enzyme is able to oxidize non-acetylated spermine (Vujcic et al.,
2002b). The human SMO is a flavin-containing oxidase that acts on
spermine (Km = 1.6 µM) and N1-acetylspermine (Km = 51 µM). However, it does
not  oxidize  spermidine  (Wang  et  al.,  2003).  The  products  of  the  SMO  reaction
are spermidine, hydrogen peroxide and 3-aminopropanal. The human Smox
gene has been demonstrated to undergo alternative splicing creating up to four
different isoforms, with each isoform having different substrate preferences and
expression patterns (Murray-Stewart et al., 2002). In contrast to APAO, SMO
13
expression is highly inducible at the mRNA level by various polyamine
analogues, such as N1, N11-bis(ethyl)norspermine (Wang et al., 2001b). While the
APAO  inhibitor  MDL  72,527  is  also  able  to  suppress  SMO  activity,  the
oligoamines SL-11144 and SL-11150 have been demonstrated to be more potent
inhibitors with IC50 values lower than 0.1 µM (Wang et al., 2003). One
hypothesis  claims  that  the  reason  for  the  existence  of  SMO  could  be  the
production of ?-alanine from 3-aminopropanal via aldehyde
dehydrogenase (Vujcic et al., 2002b), as happens in the yeast SMO catalyzed
reaction (White et al., 2001).
 2.4 POLYAMINE TRANSPORT
The vast majority of polyamines found in the cell originate from the diet and/or
the  gut  flora.  Therefore,  polyamine  uptake  is  a  crucial  mechanism  in
maintaining intracellular polyamine levels. The polyamine transporter needs to
have three main properties: a high affinity for spermine and spermidine, while
the affinity of putrescine needs to be lower; fast transport speed (2-5 nmol/106
cells/h); a feedback control (OAZ) (Mitchell et al., 2007).
Recently, Soulet et al (2004) proposed a comprehensive model for the
cellular polyamine transport. According to the proposed mechanism, polyamine
transport into the cells consists of two differentiated steps. The first step occurs
at the plasma membrane, where polyamines are transported into the cytosol
through  an  as  yet  to  be  discovered  channel  or  uniporter  that  only  needs  an
electronegative membrane potential (Poulin et al., 1998). It has also been
suggested that the heparan sulfate side chains of glypican-1 can act as
polyamine presenters for the polyamine transporter (Belting et al.,  2003). In the
second step, the intracellular polyamines are transported and stored into
polyamine-sequestering vesicles formed from the transgolgi network. The
transport  into  the  vesicles  is  an  energy  consuming  process  controlled  by  a
proton  gradient  maintained  by  vesicular  ATPase,  and  thus  the  number  of
protons  to  be  excreted  is  equivalent  to  the  total  number  of  charges  of  the
polyamine  to  be  imported.  Therefore,  the  vesicle  transporter  would  be  a
proton:polyamine  antiporter.  It  is  rather  likely  that  the  release  of  polyamines
from the polyamine-sequestering vesicles is performed by the same
proton:polyamine antiporter.
The polyamine transport mechanism takes up spermine and spermidine
with a high affinity (Km < 1 µM), and putrescine with a lower affinity (Km = 5-10
µM)  (the  first  and  second  characteristics  of  the  polyamine  transporter),  but  it
appears that these molecules are not the only ones transported into the cell by
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this  transporter.  Many  of  the  known  polyamine  analogues  seem  to  be
transported by the same mechanism as the natural polyamines and with similar
Km values. Moreover, other molecules, such as methylglyoxal
bis(guanylhydrazone) or paraquat, with little structural resemblance to
polyamines, are transported by the same mechanism (Seiler et al., 1996).
Polyamine uptake is controlled by OAZ through an unknown
mechanism (Coffino 2001) (the third characteristic of the polyamine transporter).
OAZ is activated when intracellular levels of free polyamines become elevated
and functions by inhibiting polyamine biosynthesis and polyamine uptake.
The excretion of polyamines seems to use a different mechanism than
their import. The polyamine exporter, named the diamine exporter, is regulated
by  the  transmembrane  pH  gradient  (Xie  et  al.,  1997).  Polyamines  are  excreted
either  as  putrescine  or  as N1-acetylated polyamines formed by the SSAT
catalyzed reaction. Recently, a putative polyamine exporter has been
characterized as the solute carrier 3 A2 transporter (SLC3A2). SLC3A2 couples
putrescine excretion with arginine uptake. Moreover, the SLC3A2 colocalizes in
the plasma membrane together with SSAT, evidence of a direct link between
polyamine catabolism and excretion (Uemura et al., 2008).
 2.5 FUNCTIONS OF POLYAMINES
The characteristic chemical structure of the polyamines, namely the backbone
with differentially spaced amino groups (Figure 1), means that under
physiological conditions, most of the intracellular polyamines are positively
charged. The positive charges from the polyamines allow them to interact with
many different cellular components, such as DNA to RNA and proteins. In fact,
it  is  believed that  most  of  the polyamines in  the cell  are  not  free  but  bound to
cellular components (Jänne et al., 2004). The general distribution of polyamines
combined with their chemical characteristics means that they are critically
involved in many basic cellular functions.
 2.5.1 DNA interaction
The positive charges of the polyamines are differentially interspaced along their
backbone (Figure 1). This particular characteristic is a central feature allowing
their  interaction  with  polynucleotides.  Polyamines  are  able  to  condense  DNA,
either naked or in the form of chromatin. The formation of chromatin requires
the  compaction  of  DNA  which  folds  itself  with  the  aid  of  histones.  However,
histones by themselves can only neutralize about 55% of the negative charges on
DNA (Smirnov et al., 1988). When histones are combined with polyamines, they
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can neutralize an additional 15-30 % of the negative charges, thus, neutralizing
most of the negative charges. This means that the DNA folding into chromatin
can be accomplished more easily in the presence of polyamines (Balasundaram
and Tyagi, 1991). This is achieved in a stochiometric manner, i.e. two polyamine
molecules are needed per DNA turn (Smirnov et al., 1988).
More related to the polyamine metabolizing enzymes than to the
polyamines themselves, histones can be modified by methylation, acetylation or
phosphorylation. Already in 1980, there were reports of histone
acetyltransferase enzymes that also possessed the capability to acetylate
polyamines (Libby 1980). Accordingly, the SSAT enzyme is a member of the
GCN5 acetyltransferases family. GCN5 acetyltransferases are able to acetylate
various  residues  in  the  tails  of  yeast  histones  H3  and  H2B  (Baker  and  Grant,
2007), decompressing chromatin and making it transcriptionally active.
Therefore, there is a tight relationship between chromatin structure and
polyamine metabolism. This was also postulated by Morgan et al. (1987) who
proposed that the existence of acetyltransferases capable of acting upon both
histones and polyamines serves as evidence for the relationship of these two
processes.
Polyamines have also been implicated in the “transformation” of
B-DNA (the right-handed helix), the most common form of DNA, into
Z-DNA (the left-handed zig-zag). The Z-DNA conformation appears in regions
where alternative pyrimidine and purine bases occur. These regions are present
regularly at every 3000 base pairs in the human genome, and have been found
to be preferentially located near to the transcription initiation sites (Schroth et
al.,  1992). By themselves, micromolar levels of spermidine or spermine are able
to transform DNA from the B to the Z conformation (Thomas et al., 1985). Ha et
al. (2005) demonstrated that a single DNA chain could present both B and Z
structures at the same time. This is possible when the base at the junction of the
two  conformations  is  broken  and  flips  out.  DNA  in  the  Z  conformation  is
released  from  the  nucleosome  and  it  cannot  reform  it.  The  Z  conformation  is
transcriptionally active as it attracts transcription factors and RNA polymerases
that initiate transcription (Liu et al., 1987). Thus, it is possible that the
intracellular levels of polyamines, in particular the intranuclear pool, helps to
regulate  the  transcription  of  genes,  by  means  of  controlling  the  B  to  Z  DNA
conformational change.
 2.5.2 Eukaryotic cell cycle
The progression of the cell cycle depends on the activation of the different
constitutively expressed cyclin dependent kinases (CDKs) by the appropriate
regulatory cyclins (reviewed by Malumbres and Barbacid, 2009). Together with
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the  cyclic  behavior  of  the  pairs  of  CDKs  and  cyclin,  polyamine  concentration
and  their  metabolic  enzymes  follow  distinct  cyclic  patterns  during  the
eukaryotic cell cycle.
The polyamine biosynthetic enzymes ODC and AdoMetDC are first
activated  during  the  late  G1  phase,  and  reach  their  first  activity  peak  at  the
beginning  of  the  S  phase.  A  second  activation  occurs  during  the  late  S  phase,
reaching a peak at the G2 phase, not declining until after the
G2/M transition (Oredsson, 2003). SSAT is also expressed following the cell cycle
progression. SSAT is activated only after the G2/M transition, peaking at the
M phase and decreasing rapidly afterwards. In accordance with ODC and
AdoMetDC activation, the polyamine content also varies, with peaks at the time
when ODC appears activated (Wallace et al., 2003). Whether the alterations in
the polyamine metabolism are a cause or an effect of the cell cycle progression is
not completely clear. What it is clear is that specific amounts of each individual
polyamine are needed to allow cells to progress through the cell cycle, but their
particular functions remain undetermined (Oredsson, 2003) (Figure 3).
One  possible  function  of  polyamines  in  the  cell  cycle  was  proposed  by
Thomas and Thomas (1994) who showed that polyamines could regulate the
degradation of cyclin B1. Therefore, the alterations in the polyamine pools
during the cell cycle may be due to their role in cyclin regulation. Irrespective of
what the exact functions of polyamines are within the cell cycle, alterations on
the polyamine metabolism have profound effects on hyperproliferative diseases.
 2.5.3 Hypusine formation
Spermidine has one particular function since it is the precursor for the amino
acid hypusine (Shiba et al., 1971). Hypusine is a rather unique amino acid that is
needed for the formation of the functional form of the eukaryotic initiation
factor 5a (eIF-5a, previously known as eIF-4D) (Park 1989). eIF-5a is produced in
a two-step reaction (Park et al., 1982). In the first step, spermidine is hydrolysed
by  deoxyhypusine  synthase  (DHS)  and  the  released  4-aminobutyl  group  is
transferred to the ?-amino group of the 50Lys residue from the eIF-5a precursor
protein. In the second step, the deoxyhypusinated precursor is hydroxylated by
deoxyhypusine hydroxylase (DOHH) producing the mature eIF-5a. The exact
function of eIF-5a has remained as elusive as the functions of polyamines
themselves. Among other, eIF-5a has been linked to the formation of the first
peptide bond during mRNA translation (Benne and Hershey, 1978), it serves as a
cofactor for HIV-1 REV (Ruhl et al., 1993), and is involved in the nuclear
export (Lipowsky et al., 2000) and mRNA turnover (Zuk and Jacobson, 1998).
Due  to  the  lack  of  a  specific  function  for  spermine  in  the  higher  eukaryotes,  it
has  been proposed that  spermine could serve as  a  reserve pool  for  spermidine
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used in the formation of hypusine (Hyvönen et al., 2007b).
Figure 3. Polyamine levels and main polyamine metabolizing enzymes are
altered during the eukaryotic cell cycle (modified from Wallace et al., 2003;
Oredsson, 2003).
 2.5.4 Ion channels
Polyamines are also capable of interacting with various ion channels, such as
potassium inward rectifying (Kir) channels, ?-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) and kainate receptors, and
N-methyl-D-aspartate (NMDA) receptors (Johnson, 1996; Williams, 1997). The
total  charge  of  the  polyamine  cation  directly  correlates  to  its  affinity  on  the
specific ion channel (spermine >> spermidine >> putrescine). In the Kir, AMPA
and kainite  receptors,  polyamines interact  with the actual  gate,  blocking it  and
making it impossible for other molecules to pass through. On the other hand, in
the NMDA receptors,  spermine has  a  triple  effect:  it  potentiates  currents  in  the
presence of glycine (a co-activator); increases the affinity of the receptors for
glycine; and decreases the affinity for glutamate (Williams, 1997). As a curiosity,
some  spider  and  wasp  venoms  contain  toxins  that  are  formed  by  an  aromatic
group linked to a polyamine-like tail. These polyamine-derived toxins are able
to affect the same group of ion channels as normal polyamines. This property is
currently being used in the design of new synthetic selective inhibitors for the
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different ion channels (Strømgaard et al., 2005).
 2.5.5 Free radical scavenging
Polyamines, in particular spermidine, have been linked with the ability to
scavenge  free  radicals  and  to  protect  DNA  against  reactive  oxygen
species (ROS) (Ha et al., 1998). Moreover, lipid peroxidation, the process by
which free radicals remove negative charges from lipids in the cell membrane
producing cellular damage, is inhibited by polyamines (spermine >> spermidine
>> putrescine) in protozoa (Trypanosoma cruzi) (Hernández et al., 2006), in rat
liver homogenates (Pavlovic et al., 1992), and human red blood cells (Farriol et
al., 2003).
 2.6 POLYAMINES AND DISEASE
The  polyamine  functions  identified  so  far  are  many  and  diverse.  Therefore,  it
could be expected that alterations in polyamine metabolism and their levels
would affect, or be affected, in a wide variety of disease states.
 2.6.1 Inflammation
Inflammation is the organism’s response to cellular damage. Inflammation per se
is not a disease but a consequence of one. Acute inflammation is the response to
cellular damage or injury. During the first steps, resident macrophages and mast
cells release inflammatory mediators, such as cytokines, chemokines and
eicosanoids.  These  mediators  are  used  to  recruit  circulating  leukocytes  and
plasma proteins into the injured area. Neutrophils become activated, either by
direct  contact  with  the  pathogens  or  can  be  activated  by  the
cytokines  (chemotaxis),  and then these  cells  move into the injured area and try
to remove the pathogens by phagocytosis and/or releasing the contents of their
granules (degranulation). The neutrophil granules contain, many potent
effectors, including ROS and reactive nitrogen species. These effectors cannot
differentiate between the endogenous and exogenous components. Thus, the
organism also suffers some damage during the inflammatory process. Once the
pathogen responsible for the original damage has been removed, the repair
phase can begin. Resident macrophages release lipoxins that enhance the
recruitment of monocytes that will remove dead cells and initiate the tissue
repair. However, if the inflammation signaling continues to be active, the acute
inflammation will be converted into a chronic condition. During chronic
inflammation, the constant activity of macrophages produces elevated amounts
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of cytokines and ROS evoking DNA and cellular damage (reviewed by
Medzhitov 2008). Chronic inflammation has been linked to many different
diseases, from type 2 diabetes (Ray et al., 2009), to cardiovascular
diseases (Duan et al., 2009), cancer (Rakoff-Nahoum, 2006),
pancreatitis (Granger and Remick, 2005) and stroke (Kleinig and Vink, 2009), all
of them being also associated with alterations in the polyamine metabolism.
The pro-inflammatory cytokine, tumor necrosis factor ? (TNF?), is
released upon activation of the inflammation pathway. TNF? activates SSAT in a
non-small cell lung carcinoma cell line via the action of nuclear factor
?? (NF??) (Babbar et al., 2006). NF?? binds to the NF?? response element
found  in  the  SSAT  promoter  region  (Choi  et  al.,  2006).  The  increased  SSAT
activity after the inflammatory process decreases the polyamine pools and slows
down  the  cell  growth  rate.  As  a  side  effect  of  the  increased  SSAT  activity,
elevated amounts of hydrogen peroxide will be produced this could cause DNA
damage and cellular apoptosis leading to persistence of the
inflammation (Babbar et al., 2007). On the other hand, spermidine and spermine,
which would be depleted after  SSAT activation,  have been found to  inhibit  the
secretion of TNF? in cultured macrophages (Pérez-Cano et al., 2003) and human
peripheral blood mononuclear cells (Zhang et al.,  1997). Therefore, they can be
considered as having anti-inflammatory effects.
 2.6.2 Cancer
Most of the attention that polyamines have attracted comes from their
involvement in hyperproliferative disorders. As discussed above, polyamine
levels and the activities of the related enzymes are suggested to control the
movement of cells through the cell cycle (Figure 3).  Therefore,  it  is  to  be
expected that alterations in polyamine metabolism and pools are intimately
involved in the development of hyperproliferative diseases.
During the mid 1960s appeared the first reports indicating that
polyamines accumulate in rapidly growing tissues, such as chick
embryo (Caldarera et al., 1965) or regenerating rat liver (Raina and Jänne, 1968;
Russell  and  Snyder,  1968).  The  interest  in  polyamines  and  cancer  originated
during  the  late  1960s  and  in  the  early  1970s,  when  various  reports  linking
alterations in the polyamine levels or polyamine-related enzymes with cancer
appeared (Bachrach et al., 1967; Williams-Ashman et al., 1972; O'Brien et al.,
1975). Moreover, at the same time it was reported that 70 to 90% of human
patients suffering from any form of cancer excreted high levels of polyamines in
their urine (Tsuji et al., 1975; Russell 1971), making urinary polyamines levels a
good  prognostic  marker  for  cancer.  This  correlation  between  polyamines  and
cancer led to the hypothesis that controlling the polyamine cycle could alter the
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cancer progression, and this spurred the development of specific polyamine
metabolism inhibitors, such as ?-difluoromethylornithine (DFMO) (Metcalf et
al., 1978). The treatment of cancer by using single enzyme inhibitors has proven
unsuccessful, mainly because either these inhibitors were not able to deplete the
cells from all three polyamines or they had toxic side effects (Wallace and Fraser,
2003). These initial failures with the single enzyme inhibitors inspired the search
for polyamine analogues. Polyamine analogues are designed either to substitute
completely the natural polyamines in their cellular functions or to be
cytotoxic (Casero and Marton, 2007).
The most detailed account of the relation between polyamine metabolism
and cancer is depicted in the mechanism of action of the genetic variant of colon
cancer called familial adenomatous polyposis (FAP). Individuals suffering from
FAP  possess  a  germline  mutation  in  the  tumor  suppressor  adenomatous
polyposis coli (APC) gene. The mutation has a double effect, first it produces the
loss  of  APC  function,  and  second,  it  induces  expression  of  the  c-Myc
oncogene (He et al., 1998). The first gene found to be transcriptionally regulated
by c-Myc was ODC (Bello-Fernandez et al., 1993). ODC is transcriptionally
regulated in FAP cancer through two connected pathways. In the first pathway,
functional APC suppresses the activation of c-Myc and activates OAZ, and this
combined effect represses ODC activity and increases its degradation by the 26S
proteasome  (Erdman  et  al.,  1999).  This  is  demonstrated  in  a  FAP  mouse
model (APCMin/+ mouse) that displays increased ODC expression in the intestinal
tissue (Erdman et al., 1999). The second pathway involves the activation of V-Ki-
ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS). KRAS is usually
inactive,  but  in  many types of  cancer  it  becomes mutated and activated,  e.g.  in
colon cancer. Activated KRAS blocks SSAT transcription by means of repressing
the  PPAR? protein  (Ignatenko  et  al.,  2004),  a  known  SSAT  activator  (Babbar  et
al., 2003). Moreover, activated KRAS has been demonstrated to block the
diamine exporter (SLC3A2) in the HCT116 colon cancer cell line (Uemura et al.,
2008). The combination of these processes (ODC activation, SSAT repression and
polyamine  export  blockage)  wakes  the  accumulation  of  polyamines  in  the
intestinal cells, leading to increased proliferation and finalize with
neoplasia (Gerner and Meyskens, 2004) (Figure 4).
The study of the FAP colon cancer mechanism allowed the clarification of
a possible link between polyamine metabolism and cancer. Similar alterations in
the polyamine metabolism appear to occur in most cancer types, as c-Myc is
estimated to be upregulated in 70 % of human tumors (Casero and Marton,
2007).
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Figure 4. Alterations of polyamine metabolism in FAP colon cancer. Wild-type
APC inactivates c-Myc, a known ODC activator, and activates OAZ, the ODC
regulator protein. While the mutated APC is not able to block ODC activation by
c-Myc. Additionally, mutated and activated KRAS inhibits PPAR?, blocking and
decreasing SSAT activity. At the same time, the repressed SSAT negatively regulates the
expression of SLC3A2. The combination of all these processes leads to the intracellular
accumulation of polyamines, by activating polyamine biosynthesis and repressing
polyamine catabolism and excretion, and malignant cellular growth. Lines with a square
indicate repression (??), and lines with a double arrowhead indicate
activation (???) (modified from Gerner and Meyskens, 2004).
 2.6.3 Type 2 diabetes
Type  2  diabetes  (T2D)  is  an  endocrinological  disorder  that  arises  when
pancreatic beta-cells are not capable to secrete enough insulin in response to the
serum glucose levels. This imbalance occurs due to a decreased beta-cell mass
and/or secretory dysfunction (Rhodes, 2005), combined with the appearance of
insulin  resistance  in  peripheral  organs,  such  as  adipose  tissue,  muscle  and
liver (Laakso, 2001). A combination of both genetic and environmental factors is
responsible for the development of T2D. The results from candidate gene
studies  combined  with  recent  genome-wide  association  (GWA)  studies  have
identified  so  far  a  total  of  19  candidate  genes  related  to  the  development  of
T2D (McCarthy and Zeggini, 2009). Among the several environmental factors,
the  activity  regime  and  the  diet  are  the  two  main  causes  affecting  the
development of T2D. In fact, obesity, specifically the amount of abdominal fat,
has been positively correlated to insulin resistance in man (Abate et al., 1995).
The number of people suffering from T2D was estimated to be around 170
million worldwide in the year 2000, and if the trend continues, it is expected that
by the year 2030, it will more than double to about 366 million people (Wild et
al., 2004).
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Polyamines  are  found  in  all  living  cells,  and  pancreas  and  the
insulin-producing beta-cells are no exception. In fact, the pancreas is the organ
containing the highest concentration of intracellular spermidine and
spermine (Rosenthal and Tabor, 1956). It is clear that polyamines have a role in
insulin secretion. The two polyamines, spermidine and spermine, are localized
in the secretory granules found in the beta-cell cytoplasm (Hougaard et al.,
1986). These polyamines can be used as a substrate by the enzyme
transglutaminase (Folk et al., 1980), which modulates membrane fusion
processes in the beta-cells (Bungay et al., 1984). Moreover, spermidine and
spermine  seem  to  be  directly  involved  in  the  transcriptional  control  of  the
insulin gene (Welsh, 1990).
Research  performed  in  our  group  has  recently  demonstrated  that  a
transgenic mouse line overexpressing the SSAT gene under its own promoter
has 66% reduced perigonadal white adipose tissue (WAT), improved insulin
sensitivity and glucose tolerance, and increased expression of PPAR ?
co-activator 1? (PGC 1?), which controls many oxidative
phosphorylation (Pirinen et al., 2007). Moreover, studies using a knockout
mouse  line  with  a  disrupted  SSAT  gene  have  revealed  that  these  animals
become insulin resistant upon ageing (Niiranen et al., 2006) and that they
accumulate more adipose tissue than wild-type mice (Jell et al., 2007). A detailed
characterization of these two mouse lines showed that the transgenic mice have
decreased  acetyl  and  malonyl-CoA  levels  in  the  white  adipose  tissue,  and
elevated glucose and palmitate  oxidation,  while  the knockout  animals  have an
opposite phenotype, with increased levels of acetyl and malonyl-CoA and
decreased glucose and palmitate oxidation (Jell et al., 2007). The decreased level
of acetyl-CoA is a direct result of the polyamine catabolism activation, which
uses two acetyl-CoA molecules per turn. Moreover, the activation of polyamine
metabolism increases consumption of ATP equivalents, in the form of dcAdoMet
and  acetyl-CoA.  This  increased  energy  demand  in  the  SSAT  overexpressing
animals is thought to be the basis for the increased insulin sensitivity (Pirinen et
al., 2007). This association is currently under intensive study by our group and
others as it could represent novel approach to the treatment of T2D and obesity.
 2.6.4 Pancreatitis
The function of  the large pancreatic  spermidine pool  is  not  clear  but  it  may be
involved either in the active protein synthesis or the secretory
mechanism (Jänne et al., 2005), as hypothesized earlier for the insulin secretion.
Transgenic rat and mouse lines harboring the SSAT gene under the
control of a mouse heavy metal-inducible metallothionein I promoter have been
extensively used in the study of pancreatitis (Alhonen et al.,  2000; Herzig et al.,
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2005).  Upon  activation  of  the  SSAT  transgene  by  a  non-toxic  dose  of  Zn,  the
spermidine and spermine pools are depleted while putrescine accumulates, and
this is accompanied by acute necrotizing pancreatitis (Alhonen et al., 2000). The
activations of cathepsin B and trypsinogen, both early signs of pancreatitis
injury, correlate temporally with the spermidine pool depletion. Structurally the
pancreas  is  also  affected  by  the  spermidine  and  spermine  depletion,  showing
dilation  of  the  rough  endoplasmic  reticulum,  appearance  of  autophagosomes
and, later, the disruption of intracellular membranes and organelles (Hyvönen
et al., 2007a). Pancreatitis development is linked also with reactive oxygen
damage leading to inflammation. Merentie et al. (2007) showed that the
MT-SSAT transgenic rats display increased lipid peroxidation, a clear sign of
reactive oxygen damage, decreased superoxide dismutase and catalase
activities, and activation of pro-inflammatory cytokines, such as IL-1? and
TNF-?. More evidence of the direct involvement of polyamines in the
development of pancreatitis came from an experiment where SSAT transgenic
rats were treated with a polyamine analogue, ?-methylspermidine (Räsänen et
al., 2002) or bis-?-methylspermine (Merentie et al., 2007), before the induction of
pancreatitis. These treatments prevented the development of the pancreatitic
damage and the induction of inflammatory factors. Moreover, bis-?-methyl
spermine was shown to abolish completely trypsinogen activation in isolated
MT-SSAT acini (Hyvönen et al., 2006). Other chemically induced pancreatitis
models, such as the taurodeoxycholate (Jin et al., 2008) or gossypol (Räsänen et
al., 2003), show similar changes in the polyamine pools.
 2.6.5 Protozoan parasites
Polyamines, with the exception of spermine, are also found in protozoan
parasites. Spermidine is used by the parasites to produce trypanothione, a
spermidine-bis(glutathionyl) conjugate used for protection against oxidative
and  chemically  induced  stress.  Therefore,  drugs  aimed  at  interfering  with  the
polyamine metabolism are promising targets for the fight against protozoan
parasites diseases (Heby et al., 2007). During the 1980’s, it was demonstrated
that  treatment  with  DFMO  was  able  to  cure  mice  infected  with Trypanosoma
brucei brucei (Bacchi et al., 1980), and also humans infected with Trypanosoma
brucei gambiense,  one  of  the  parasites  responsible  for  African
trypanosomiasis (African sleeping sickness) (van Nieuwenhove et al., 1985).
However, DFMO has not been effective against the trypanosoma strain
responsible for the sleeping sickness, Trypanosoma brucei rhodesiense. Other
parasitic diseases that can be treated with inhibitors of polyamine
biosynthesis (DFMO or AbeAdo) include Chagas disease (American
trypanosomiasis) caused by the T. cruzi, and Leishmaniasis (Heby et al., 2003).
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 2.6.6 Other diseases
Sequeira et al (2006) identified a correlation between low SSAT expression and
suicidal tendencies. A microarray analysis further demonstrated that individuals
attempting or committing suicide display lower SSAT levels in the brain. The
same group later demonstrated the existence of three different polymorphisms
in the promoter region, an insertion/deletion (rs6151267) and two
SNPs (rs6526342 and rs928931). These polymorphisms may affect SSAT
expression levels even without involving the polyamine response
element (PRE) (Fiori et al., 2009). A similar study contrary reported that
although  successful  suicides  have  lower  SSAT  expression  levels  in  the  brain,
there was no correlation between the SSAT expression levels and the
SNPs (Guipponi et al.,  2008). The differences between the two studies could be
due  to  different  areas  of  the  brain  that  were  sampled.  Since  SSAT  can  be
considered as a stress response protein, Fiori et al.  (2009) hypothesized that the
lower levels of SSAT found in the SNP carriers could affect their capacity to deal
with the consequences of stress, promoting suicidal tendencies on the carriers.
The Snyder-Robinson syndrome (OMIM 309583) is a very rare mental
retardation syndrome linked with mutations in the SMS gene. This syndrome is
characterized by mildtomoderate mental retardation, asthenic body build,
skeletal  defects,  osteoporosis,  and unsteady gait.  Since the SMS gene is  located
in the X chromosome, the syndrome only affects males. There are three reports
on three different families affected by the Snyder-Robinson syndrome, and each
of these families carries a different mutation in the SMS gene (Cason et al., 2003;
de Alencastro et al., 2008; Becerra-Solano et al., 2009).
The rare X-linked disorder keratosis follicularis spinulosa
decalvans (OMIM 308800) has been linked with the duplication of a
chromosomal  region,  giving  rise  to  an  additional  SSAT  gene  in  one  single
patient. Keratosis follicularis spinulosa decalvans is characterized by follicular
hyperkeratosis, progressive cicatricial alopecia, and photophobia. Studies on
fibroblasts isolated from the original patient identified an increased putrescine
concentration  and  decreased  spermidine  and  spermine  levels  (Gimelli  et  al.,
2002). This phenotype bears many resemblances with the symptoms seen in
rodent models where there is increased polyamine catabolism, namely
hairlessness, wrinkled skin, depletion of spermidine and spermine and
accumulation of putrescine (Pietilä et al., 1997; Suppola et al., 1999).
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 3 Aims of the study
The main aim of this study was to extend the current knowledge on polyamine
functions and metabolism. In order to achieve this goal, advantage was taken of
a variety of transgenic mouse models. The majority of the present work is based
on studies performed on a transgenic mouse model overexpressing the SSAT
gene under the control of the metallothionein promoter (MT-SSAT), but also a
mouse model overexpressing the SSAT gene under its own promoter and a
mouse model with a disrupted SSAT gene (SSATKO) were used.
The specific aims of the study were:
? To test  the stability  of  ?-methylated polyamine analogues and whether
these analogues are able to substitute natural polyamines in vivo in the
presence of activated polyamine catabolism (MT-SSAT) (Original
Publication I)
? To analyze the hepatic protein expression pattern in a mouse line with
activated polyamine catabolism (MT-SSAT) (Original Publication II)
? To characterize the accelerated aging phenotype linked with activated
polyamine catabolism seen in the MT-SSAT mouse line (Original Publication
III)
? To  improve  the  current  methodology  used  for  the  polyamine  flux
studies (Original Publication IV)
? To characterize the link between activated polyamine catabolism and
altered insulin secretion (MT-SSAT)
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 4 Materials and methods
 4.1 ANIMAL MODELS (I, II AND III)
The generation of MT-SSAT transgenic mice (UKU181) (Figure 5)  has  been
previously described. Briefly, both the metallothionein I promoter and the SSAT
coding  sequence  used  for  the  transgene  construct  were  cloned  from  a  mouse
genomic  DNA  library.  The  transgenic  mice  were  generated  by  a  standard
pronuclear microinjection to zygotes from BALBc x DBA/2 females mated with
CD2F1 males (Suppola et al., 1999). The animals were housed in the National
Laboratory Animal Center of Kuopio University under controlled
temperature (20 ± 2°C) and relative humidity (50 %), a 12-hours light cycle, and
were fed a standard chow diet ad libitum, unless otherwise stated. All the animal
experiments were approved by the Institutional Animal Care and Use
Committee at the Provincial Government of Eastern Finland.
 4.2 ANALYTICAL METHODS (I, II, III AND IV)
 4.2.1 SSAT activity (I, II, III and IV)
SSAT activities were assayed following the method of Libby (1978). In short,
tissue and cell homogenates were centrifuged for 30 min at 13,000 rpm at
+ 4°C (Heraeus Biofuge Fresco, Thermo Scientific, Walthman, MA, USA). A
volume  of  10  µl  of  the  supernatant  was  transferred  into  0.5  ml  tubes.  Samples
were incubated in  duplicates  for  10  min at  37°C with 100 mM Tris-HCl pH 7.8,
10  mM  spermidine,  1  mM  DTT,  and  0.5  nCi  [14C]-acetyl-CoA (0.5 µCi/ml, GE
Healtcare,  Uppsala,  Sweden)  in  a  final  volume  of  100  µl.  After  the  incubation,
20 µl of hydroxylamine hydrochloride were added and the mixture was further
incubated  at  99°C  for  3  min  in  order  to  inactivate  the  enzyme.  The  tubes  were
centrifuged  for  3  min  at  13,000  rpm  to  remove  any  protein,  and  40  µl  of  the
supernatant were spotted on a phosphocellulose P81 paper (1 cm2)  piece.  The
papers  were  dried  for  10  min  and  then  extensively  washed  with  MilliQ  water
and ethanol. Finally, the papers were dried and placed in scintillator tubes with
3 ml of Optiphase Hisafe 2 (Perkin Elmer, Shelton, CT, USA) and measured in a
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liquid scintillator counter (1450 Microbeta Plus, Perkin Elmer).
 4.2.2 ODC activity (III)
ODC  activities  were  assayed  with  the  method  of  Jänne  and
Williams-Ashman (1971). Cellular extracts were centrifuged for 30 min at
13,000 rpm at + 4°C. A total of 50 µl of the supernatant was transferred into glass
tubes, preparing duplicates per sample. 200 µl of a solution containing 125 mM
Tris-HCl pH 7.4, 5 mM EDTA, 5 mM DTT, 250 nM L-ornithine, 0.5 mM pyridoxal
phosphate, and 0.2 µCi [14C]-L-ornithine (0.02 µCi/µl, GE Healtcare) was added
to  each  of  the  samples,  and  a  piece  of  Whatman  paper  soaked  in
Soluene (Sigma-Aldrich, Stenheim, Germany) was attached to the top of the
tube.  The  reaction  tubes  were  incubated  for  30  min  at  37°C  with  constant
shaking. After the incubation, 1 ml of 2 M citric acid was added and the mixture
was further  incubated at  37°C for  5  min in  order  to  terminate  the reaction and
liberate the remaining CO2 from  the  solution.  The  papers  were  placed  into
scintillator tubes with 3 ml of Optiphase Hisafe 2 and measured in liquid
scintillator counter.
Figure 5. Two MT-SSAT transgenic mice (hairless) together with a
non-transgenic littermate of the same age.
 4.2.3 Polyamine levels (I, II, III, IV and V)
Polyamine  levels  in  the  experiments  presented  in  manuscripts  I,  II,  III  and  V
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were measured using the HPLC-based method of Hyvönen et al. (1992). The
polyamine  levels  in  study  IV  were  measured  using  the  LC/MS-MS-based
method  of  Häkkinen  et  al.  (2008).  The  protein  contents  of  the  tissue  and  cell
samples were precipitated in a 5 % sulfosalicylic acid solution containing 10 µM
diaminoheptane (DAH), used as internal standard. The samples were vortexed
and then centrifuged for 30 min at 13,000 rpm at + 4°C. The supernatants were
filtered through a 0.22 µm filter and transferred into HPLC vials.
 4.2.4 Nucleoside levels (II and III)
AdoMet and AdoHcy were measured using the HPLC-based method of She et
al. (1994). The samples were prepared in the same way as the polyamine
samples.
 4.2.5 ATP levels (II)
ATP levels were measured using the ATP Lite 1 step kit (Perkin Elmer). Tissues
were homogenized in 10 volumes of 5 % perchloric acid. The homogenates were
centrifuged for 20 min at 13.000 rpm at + 4°C, and the obtained supernatant was
neutralized  to  pH  7  using  3.75  M  K2CO3. The neutralized supernatant was
centrifuged  for  15  min  at  13,000  rpm,  and  their  supernatants  were  diluted  to
1/100 prior to the ATP measurement. Each sample was run in triplicate.
ATP levels from pancreatic islets were measured in triplicate from 10 islets
placed  in  100  µL  of  Hank’s  Buffered  Salt  Solution  (HBSS,  Gibco,  Invitrogen,
United Kingdom) containing 0.5 % BSA (Sigma-Aldrich) and 20 mM HEPES.
 4.2.6 Protein carbonyl content (III)
The  protein  carbonyl  content  was  measured  as  the  absorbance  at  370  nm
produced  by  the  carbonyl  groups  after  they  have  reacted  with
2,4-dinitrophenylhydrazaine (DNPH, Sigma-Aldrich) (Levine et al., 1990).
 4.2.7 Catalase activity (II and III)
Catalase activity was measured from tissue homogenates as the decrease of
absorbance at 240 nm (Aebi 1984).
 4.3 TWO-DIMENSIONAL POLYACRYLAMIDE GEL
ELECTROPHORESIS (2D-PAGE) (II)
The  2D-PAGE  is  based  on  the  separation  of  proteins  using  two  of  their
physicochemical properties. The first property is the protein isolectric point (pI),
29
the pH at which the protein net charge becomes 0 and the second property is the
protein mass. The two separations are performed in perpendicular directions,
therefore, creating a 2D map of the proteome. The detailed protocol used for the
2D-PAGE analysis is detailed in original publication II.
 4.4 HISTOLOGICAL ANALYSES (III)
Histology samples were placed on a tissue cassette and submerged in formalin
for at least 24h. After the formalin fixation, the samples were embedded in
paraffin and cut into sections of different thicknesses. The histological sections
were stained with hematoxylin-eosin.
 4.5 WESTERN BLOT (II AND III)
Tissues were homogenized in RIPA buffer (50 mM Tris-HCl, 150 mM NaCl,
1 mM EDTA, 1 % Triton X-100, 0.1 % SDS, 0.5 % deoxycholic acid, 10 % glycerol,
1 mM sodium vanadate, and complete EDTA free cocktail tablet (Roche,
Penzberg, Germany)). In order to remove the cellular debris, the homogenates
were centrifuged for 15 min at 13,000 rpm at + 4°C. The protein content was
measured using the Bradford protein assay (Bio-Rad,  Hercules,  CA,  USA).  The
Western blot samples contained 10 or 20 µg of protein in sample loading buffer.
The samples were boiled for three to five minutes before loading them into a
1.5 mm thick 8, 10 or 12 % polyacrylamide gel with a 4 % stacking gel. The gels
were  run  at  80  V  for  20  min  and  then  at  160  V.  The  gels  and  PVFD
membranes (Immobilon-FL, Millipore, Billerica, MA, USA) were equilibrated in
semi-dry transfer buffer (25 mM Tris, 192 mM glycine, 10 % methanol, and
0.01  %  SDS)  for  at  least  15  min.  The  transfer  of  the  proteins  from  the
polyacrylamide  gel  to  the  membrane  was  performed  on  a  Trans-Blot  SD
semi-dry transfer cell (Bio-Rad) at 15 V. The membrane was blocked with either
5  %  non-fat  milk  or  2  %  ECL  Advance  blocking  agent  (GE  Healthcare)  in  TBS
containing 0.1 % Tween-20 for 1 h at room temperature with constant shaking.
The primary antibody was diluted in TBS-Tween, and the incubation was
performed overnight at +4°C on constant shaking. The membranes were washed
in TBS-Tween using the SNAP i.d. system (Millipore), and further incubated in
secondary  antibody  diluted  in  TBS-Tween  for  1  h  at  room  temperature  on
constant shaking, and finally the membranes were washed again in TBS-Tween.
Detection was achieved using the ECL plus (GE Healthcare) and the membranes
were scanned in the Typhoon 9410 imager (GE Healthcare). The images were
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analyzed and the bands quantified with the ImageQuant TL (GE Healthcare).
 4.6 QUANTITATIVE RT-PCR (QRT-PCR) (II)
Two-step qRT-PCR (Saiki et al., 1985) was used for the quantification of
messenger  RNA  levels  for  genes  of  interest  from  liver,  muscle  and  WAT.  Total
mRNA was extracted by the guanidinium thiocyanate-phenol-chloroform
extraction method (Chomczynski and Sacchi, 1987) using the commercial
reagent TRIzol (Invitrogen, United Kingdom). An adequate amount of each
tissue was homogenized in 1 ml of TRIzol. Total RNA was further purified by
means of a chloroform extraction, and finally precipitated with the aid of
isopropyl alcohol. In order to remove any trace of genomic DNA, the extracted
total RNA was treated with DNAse I (Ambion Inc., Austin, TX, USA). The RNA
quality  was assessed spectrophotometrically  and by running the samples  in  an
1% agarose gel.  The good quality  samples  were further  processed with a  high-
capacity cDNA archive kit (Applied Biosystems, Foster City, CA, USA). Twelve
ng  of  the  produced  cDNA  (RNA  equivalents)  were  used  as  templates  for  the
qRT-PCR.  qRT-PCR  reactions  were  run  in  triplicate  together  with  a  known
standard curve in 96-well plates in an ABI Prism 7700 instrument (Applied
Biosystems). The running conditions for the qRT-PCR were as follows: 2 min at
50°C, 10 min at 95°C, and 40 cycles of 15s at 95°C and 1min at 60°C.
Gene-specific primers and Taqman probes were designed using Applied
Biosystems assay-by-design tool (Applied Biosystems,
https://www5.appliedbiosystems.com/tools/cadt).
 4.7 INTRAPERITONEAL GLUCOSE, INSULIN AND
ARGININE TOLERANCE TESTS AND INSULIN
RELEASE (II)
The  intraperitoneal  glucose  tolerance  tests  were  performed  on  four  and  eight
month  old  mice.  The  mice  were  fasted  for  12  hours  prior  to  the  test.  A  single
dose  of  2  mg/g  body  weight  of D-glucose was injected intraperitoneally and
blood from the tail vein was taken at 0, 15, 30, 60, and 120 min for glucose and
insulin analyses. In the insulin release assay, a dose of 3 mg/g body weight
D-glucose was injected intraperitoneally and blood from the tail vein was taken
at 0, 2, 5, 15, and 30 min for glucose and insulin analyses.
The insulin tolerance tests were performed on fed animals. A single dose
of 0.15 mU insulin/g body weight (Actrapid, Novo Nordisk, Denmark) was
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injected intraperitoneally and blood from the tail vein was sampled at 0, 20, 40
and 80 min for glucose analysis.
The arginine tolerance test was performed on four hours fasted animals. A
dose of 2 mg/g body weight of arginine (Sigma-Aldrich) was injected
intraperitoneally and blood was collected from the tail vein at 0, 2, 5, 15, 30 and
60 min for glucose and insulin analysis.
Plasma glucose levels were analyzed with the fluorometric
method (Passonneau and Lowry, 1993), and the insulin levels were measured
using  a  rat  insulin  ELISA  with  mouse  insulin  standards  (Christal  Chem  Inc.,
Chicago, IL, USA).
 4.8 ISOLATION OF PANCREATIC ISLETS
Fed mice were killed by CO2 and the pancreata were intraductally perfused with
a solution of 0.75 mg/ml of collagenase XI (Sigma-Aldrich). The perfused
pancreata were transferred into 15 ml tubes containing 2 ml of HBSS (Gibco)
containing  0.5  %  BSA  (Sigma-Aldrich)  and  20  mM  HEPES,  and  incubated  on
constant  shaking  at  37  °C  for  10  min.  After  the  incubation,  the  tubes  were
transferred  on  ice  and  10  ml  of  HBSS  solution  were  added,  the  islets  were
allowed to pellet by gravity and washed again with another 10 ml of HBSS
solution. After the last wash, the digestions were left in 10 ml of HBSS solution
and  the  islets  were  hand-picked  (Gotoh  et  al.,  1985).  The  islets  were  incubated
overnight in RPMI 1640 (Sigma-Aldrich) containing 1 % BSA (Sigma-Aldrich),
2 mM glutamine (Sigma-Aldrich) and 10000 U/ml penicillin and 10 mg/ml
streptomycin  (Euroclone.  Italy).  The  intact  islets  were  hand-picked  on  the  next
morning and used for the experiments.
 4.9 CELL CULTURE (IV)
E14.5 MT-SSAT embryos from C57Bl/6J females were used to isolate embryonic
fibroblasts. The cells were grown in DMEM (Sigma-Aldrich) containing 10 %
fetal bovine serum, 2mM glutamine, and 50 µg/ml gentamycin (Sigma-Aldrich).
The incubator was set to 37°C with a 5 % CO2 flux.
The cells were seeded in 100mm plates and let to grow for 24 h prior treatment.
The labeled precursors, [13C6,15N4]arginine (Isotec. Sigma-Aldrich),
[13C5,15N]methionine (Isotec. Sigma-Aldrich) or [13C5]ornithine (Cambridge
Isotope Laboratories Inc., Andover, MA, USA), were diluted to a concentration
of 0.03 g/l in DMEM without methionine (Gibco). The cells were collected at
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different time points by trypsinization and lyzed in 5 % sulfosalicylic acid. The
cells  were  sonicated  and  then  centrifuged  for  25  min  at  13,000  rpm  in  a
temperature-controlled centrifuge. The supernatants were filtered using 0.22 µm
filters (Millipore) and used to measure polyamines using the MS-based method.
The pellets were used for measurement of DNA.
 4.10 STATISTICAL ANALYSIS (I, II, AND III)
The data from the different experiments were analyzed by Student’s t-test when
two  groups  were  compared.  When  more  than  two  groups  were  analyzed,  the
one-way analysis of variance (ANOVA) with Dunnet’s post hoc test for multiple
groups comparisons was used. Data are expressed as the mean ± standard error
of the mean (S.E.M.), unless otherwise stated. Statistical analyses were
performed with the aid of the SPSS v. 16.0 (SPSS Inc, Chicago, IL, USA).
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 5 Results
 5.1 IN VIVO TESTING OF ?-METHYLATED
POLYAMINE ANALOGUES (I)
An improved methodology for the synthesis of ?-methylspermidine,
bis-?-methylspermine and ?-methylspermine in the gram scale was devised and
presented. In order to perform in vivo studies with such analogues large
amounts of these are needed. The different analogues were tested in vivo using
the MT-SSAT transgenic mice and transgenic rats, also in vitro tests using
fibroblasts derived from the transgenic rats were performed.
The in vitro study with immortalized fibroblasts derived from the
MT-SSAT rats showed that ?-methylspermidine and bis-?-methylspermine were
well tolerated up to concentrations of one millimolar. However,
?-methylspermine was shown to be quite toxic at concentrations higher than
10 µM. All three analogues dramatically reduced the natural polyamine pools in
the treated fibroblasts. Bis-?-methylspermine was the most potent of the
analogues in depleting the natural polyamines (I Figure 3). The depletion of the
natural polyamines was coupled with a slight SSAT activation in the transgenic
fibroblasts, while no signs of SSAT activation were visible in the non-transgenic
cells (I Table S18A-B).
During the in vivo tests, the different analogues were tested at several
doses  well  below  the  LD50 limit of their natural counterparts. The in vivo test
using the MT-SSAT transgenic rats indicated that all of the analogues were able
to decrease the natural hepatic and kidney spermidine and spermine pools in a
concentration-dependent manner. The pancreas did not seem to be strongly
affected by the analogue treatment since only a minor decrease in the spermine
pool was observed after treatment (I Table S17).  Moreover,  only
bis-?-methylspermine treatment induced SSAT (I Table S16).
The in vivo test using the MT-SSAT transgenic mice was more exhaustive
than the rat experiment. In the mice experiment the plasma ?-amylase and
ALAT activities were not affected by the different analogues (I Tables S1, S6 and
S11). Only the treatment with ?-mehtylspermine slightly decreased the plasma
?-amylase activity in the non-transgenic group (I Table S11).  SSAT activity was
greatly  induced  in  the  liver,  pancreas  and  kidneys  from  both  genotypes  after
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?-methylspermidine treatment. Bis-?-methylspermine treatment induced SSAT
in the pancreas of the non-transgenic line, but had no effect in the MT-SSAT
mice. ?-Methylspermine treatment affected the non-transgenic renal SSAT
activity and the transgenic hepatic and pancreatic SSAT activities. Although all
three analogues decreased the natural hepatic spermidine and spermine pools,
the total polyamine pool remained stable, indicating that the different analogues
were quite able to substitute for the natural polyamines (I Tables S3, 8 and S13).
The spermidine analogue was not metabolized during the in vivo experiment.
However, both spermine analogues, ? and bis-?-spermine, appeared to be
catabolized into ?-spermidine. The spermine analogues were metabolized only
in the livers of transgenic animals (I Tables S13 and S17).
 5.2 PROTEIN EXPRESSION ANALYSIS FROM THE
LIVERS OF MT-SSAT TRANSGENIC MICE (II)
The inducible MT promoter used for the generation of the MT-SSAT transgenic
mouse  line  targets  the  expression  of  the  transgenic  construct  mainly,  but  not
limited,  to  the pancreas  and liver.  All  of  the studied organs from the MT-SSAT
mice displayed increased SSAT expression (Figure 6).  As expected, higher SSAT
expression was detected in the pancreas and liver, followed by the small
intestine (represented by the jejunum and ileum). When comparing the changes
at the expression level, the organs with the greatest differences were
pancreas (35-fold) and liver (34-fold), followed by heart (10-fold) and
BAT (7-fold), in other organs, the increase of SSAT expression ranged from 1.5 to
5.5-fold (Figure 6 Inset).
In order to maintain the cellular polyamine levels, the transgenic cells co-
activated the polyamine biosynthesis. The simultaneous activation of the
biosynthetic and catabolic creates a futile cycle. This futile cycle can influence
the associated metabolism, such as the metabolism of methionine, urea cycle
and  acetyl-CoA.  The  generation  of  both  dcAdoMet  and  acetyl-CoA  are  energy
driven processes, and thus the increased utilization of both metabolites in the
MT-SSAT transgenic mice correlated with the 54% reduced hepatic AdoMet
levels and with the 59% reduced hepatic ATP pools (II Figures 3b and 3c).
The detailed protein expression analysis  from the livers  of  the MT-SSAT
transgenic mice detected a total of 23 proteins differentially expressed. Due to
the inherent technical limitations of the 2D-PAGE and MS techniques, only 21
spots could be positively identified. The expression profiles of the identified
proteins  showed  that  13  were  repressed,  seven  were  overexpressed,  and  one
protein  was  expressed  below  the  detection  limit  in  the  transgenic  line.  The
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complete list of the identified proteins was divided into protein families with
similar function (II Table 1). As would be expected when analyzing a transgenic
mouse line with activated polyamine catabolism, most of the identified
proteins (14) had been previously described to function in polyamine and/or the
xenobiotic metabolism. The rest of the proteins (7) did not appear to be directly
related with the polyamine and/or xenobiotic metabolisms.
Figure 6. SSAT expression pattern in different organs from the MT-SSAT
transgenic mice. The graph shows the actual expression levels. Values are expressed as
means ± SEM from three mice per line. White bars represent the non-transgenic mice,
and black bars represent the MT-SSAT transgenic mice. Values were analyzed with
Student’s mice. t-test. * p < 0.05. The inset represents the fold differences in the
activities between the non-transgenic and the MT-SSAT transgenic mice.
The detailed protein expression analysis  from the livers  of  the MT-SSAT
transgenic mice detected a total of 23 proteins differentially expressed. Due to
the inherent technical limitations of the 2D-PAGE and MS techniques, only 21
spots could be positively identified. The expression profiles of the identified
proteins  showed  that  13  were  repressed,  seven  were  overexpressed,  and  one
protein  was  expressed  below  the  detection  limit  in  the  transgenic  line.  The
complete list of the identified proteins was divided into protein families with
similar function (II Table 1). As would be expected when analyzing a transgenic
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mouse line with activated polyamine catabolism, most of the identified
proteins (14) had been previously described to function in polyamine and/or the
xenobiotic metabolism. The rest of the proteins (7) did not appear to be directly
related with the polyamine and/or xenobiotic metabolisms.
Among the proteins related to the polyamine metabolism, it was noted
that MAT1 was 1.6-fold overexpressed. AdoMet functions as a methyl donor in
most of the cell methylation reactions, a small amount is decarboxylated and can
thereafter only be used as an aminopropyl donor in the polyamine biosynthesis.
The greatly reduced AdoMet pools seen in the MT-SSAT transgenic mice could
be  part  of  a  positive  feedback  and  induce  the  MAT1  expression  in  order  to
replenish its pools. Other enzymes involved in the polyamine metabolism and
xenobiotic metabolism were GSTpi (identified in two separated spots and 68%
and 66% reduced), aldehyde dehydrogenase (2.5-fold overexpressed), and
catalase (67% reduced). The acetylation polyamine catabolic pathway produces
hydrogen peroxide and 3-acetaminopropanal as toxic by-products. The fact that
aldehyde  dehydrogenase  was  elevated  in  the  transgenic  liver  was  expected  on
the grounds that elevated intracellular levels of aldehydes were released by the
hugely activated polyamine catabolism. However, it was completely unexpected
that catalase and GSTpi, which detoxify hydrogen peroxide and protect the cell
against ROS, were repressed in the transgenic mice. It was hypothesized that as
a  result  of  the  elevated  oxidative  stress,  induced  due  to  the  activation  of  the
polyamine catabolism,  these  two enzymes should become activated in  order  to
protect the transgenic cells. Nonetheless, the analysis of their enzymatic
activities matched nicely with the 2D-PAGE results, showing that catalase
activity was reduced to 65%, while the activity of the glutathione S-transferases
was reduced to 80% in the transgenic mice (II Figure 4a and 4b).
Previous reports have shown a correlation between decreased GST pi and
selenium binding protein, and activation of PPAR ?, which is a recognized
target for PGC 1? (Chu et al., 2004; Giometti et al., 2000). Further analysis of the
PGC  1? expression  demonstrated  that  it  was  clearly  induced  in  both
mRNA (4.3-fold) and protein (3.5-fold) levels in the livers from the MT-SSAT
transgenic mice (II Figure 5a). Moreover, PGC 1? is known to control the
hepatic gluconeogenesis, and accordingly, two of the genes regulating this
factor, namely phosphoenolpyruvate carbokinase (Pepck) and
glucose-6-phosphatase (G6PC-1), were found to have increased mRNA
expression in the transgenic livers (II Figure 5b). Although activation of the
gluconeogenic program is one of the hallmarks of insulin resistance (Koo et al.,
2004), the transgenic mice appeared to be hypoglycemic and
hypoinsulinemic (II Figure 5c).  Moreover,  intraperitoneal  insulin  and  glucose
tolerance tests revealed that although the MT-SSAT displayed elevated hepatic
PGC 1? expression, the transgenic mice were clearly more insulin-sensitive and
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glucose-tolerant than their non-transgenic littermates (Figure 7).
Figure 7. Intraperitoneal glucose and insulin tolerance tests in four months old
MT-SSAT transgenic mice. a Plasma glucose (mM) and b insulin (ng/ml) levels after
the glucose tolerance test using 2mg of D-glucose/g weight. c Plasma insulin values (%
time point 0 min) after the insulin tolerance test using 0.1mU of insulin/g weight. Data
is expressed as mean ± SEM of ten mice per genotype. Non-transgenic values are
represented by the open circles (?) and MT-SSAT values are represented by the filled
circles (?).Values were statistically analyzed using Student’s t-test. * p < 0.05,
** p <0.01 and *** p < 0.001.
 5.3 PROTECTION AGAINST HEPATOTOXICITY AT
THE COST OF ACCELERATED AGING (III)
Polyamine  catabolism  has  been  proposed  as  a  source  of  oxidative  stress.  The
acetylation-oxidation polyamine catabolic pathway produces hydrogen
peroxide and 3-acetaminopropanal (Alhonen et al., 2000; Pegg 2008). The
protein  carbonyl  content,  used  as  a  measure  of  the  oxidative  state  of  an
organism, was found to be 13-fold increased in the MT-SSAT transgenic
mice (non-transgenic: 0.20 ± 0.07 nmol/mg protein; and MT-SSAT:
2.72 ± 0.47 nmol/mg protein; p = 0.0015). Surprisingly, the analysis of antioxidant
enzymes during the hepatotoxicity studies showed that catalase and Cu,
Zn-superoxide dismutase were reduced in the transgenic line by 42% and 23%,
respectively (III Table 1). These results supported the previous observations
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made  during  the  2D-PAGE  analysis  of  the  livers  from  the  MT-SSAT  mice
line  (Cerrada-Gimenez  et  al.,  2009).  Both  of  these  enzymes  are  used  in  the
degradation of hydrogen peroxide, one of the by-products of the polyamine
catabolism.  Moreover,  reduced  glutathione  (GSH),  which  is  used  to  provide
cellular protection against toxins, was greatly increased in the transgenic line,
1.5-fold in males and almost 2-fold in females. At the same time, the oxidized
glutathione (GSSG) pools were slightly increased in both genders. These
changes elicited the elevation in the GSH/GSSG ratio in the transgenic mice,
1.5-fold in females and 1.3-fold in males (III Table 1). The analysis of the liver by
DNA microarray confirmed the presence of oxidative stress and the data
revealed increased transcription of many genes involved in the cellular response
to oxidative stress, such as A170 stress-induced protein and cytoskeletal keratin
18.
Treatment with thioacetamide or carbon tetrachloride indicated that the
MT-SSAT transgenic mice were protected against the hepatic toxicity produced
by these two chemicals. Thioacetamide treatment clearly activated the
polyamine metabolism in both genotypes. The effects of carbon tetrachloride on
polyamine metabolism were less evident, with only a minor ODC activation.
The polyamine pools were modified, reducing the levels of spermine and
spermine and causing an accumulation of putrescine (III Table 2 and 3). The
intraperitoneal injection of 100 g/kg of thioacetamide evoked 33% mortality in
the non-transgenic mice, while none of the transgenic animals died during the
experiment. Moreover, treatment with thioacetamide increased the number of
binuclear cells 2-fold in the transgenic mice compared to the wild-type mice.
Carbon  tetrachloride  treatment  produced  a  similar  outcome,  with  histological
preparations  showing  only  mild  signs  of  edema  at  24  hours  post  treatment  in
the transgenic mice, while the non-transgenic group had clear signs of
periportal necrosis (III Figure 3).
The MT-SSAT transgenic mice also showed clear signs of accelerated
aging. In a long-term survival study, it appeared that the MT-SSAT transgenic
mice median life was 57 weeks, and the maximum life span was 72 weeks, about
50 % lower that the non-transgenic mice (III Figure 2). The accelerated aging
phenotype  in  the  MT-SSAT  transgenic  mice  was  associated  with  increased
expression of transcription factor p53 (III Figure 1).  One of the functions of p53
is to help in the cellular protection against oxidative stress. In order to combat
the deleterious effects of oxidative stress, transcription factor p53 is known to
become activated through the Arf pathway. However, constant activation of p53
would deplete the stem cell pool and promote accelerated aging (Matheu et al.,
2008), as seen in the MT-SSAT transgenic mice.
Aging compromises the activation of antioxidant enzymes, thus, the
decreased activities from different antioxidant enzymes seen in the MT-SSAT
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transgenic line. Moreover, the toxic effects of thioacetamide and carbon
tetrachloride are mediated through the accumulation of their metabolic
by-products. Therefore, the actual protection of the MT-SSAT mice against the
effects  of  these  two  hepatotoxic  compounds  is  likely  to  be  linked  to  the
accelerated aging phenotype and the lower activity of the antioxidant enzymes
involved in the detoxification of these toxins. A summary from the hypothesized
events leading to the phenotype seen in the MT-SSAT transgenic mice is
depicted in Figure 8.
Figure 8. Schematic representation from the course of events leading to
accelerated aging and hepatotoxic protection in the MT-SSAT transgenic mice
line.
 5.4 POLYAMINE FLUX STUDIES (IV)
The involvement of polyamines in many different disease states makes the
study of  their  metabolism essential  for  the better  understanding of  each one of
the diseases with which they have been linked. In the past, the study of
polyamine flux has been based on using HPLC to measure the incorporation of
the label from fluoro-ornithine into the polyamine pools (Kramer et al., 2008).
This method suffers many drawbacks, such as different biochemical
characteristics between the fluoro-labelled and natural compounds, and the
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limited ability of the HPLC technique to separate and quantify highly related
compounds, such as fluoro-labeled and natural polyamines. In order to
overcome these problems, it was decided to use a combination of 13C, 15N labeled
precursors with LC-MS/MS as a quantification methodology (Häkkinen et al.,
2008).
Three different mouse fetal fibroblasts cell lines were selected to represent
different states of polyamine metabolism activation: wild-type cells; MT-SSAT
transgenic cells overexpressing the SSAT enzyme; and SSATKO cells that have a
disrupted SSAT gene. The cells were cultured in a methionine-free cell media
with  one  of  the  three  labeled  precursors  used,  [13C6,15N4]arginine,
[13C5,15N]methionine or [13C5]ornithine, or in the presence of unlabeled
precursors.
Due to the different biochemical characteristics of each of the labeled
precursors, their incorporation into the polyamine pools was different.
[13C5]ornithine was incorporated at higher rates than [13C5,15N]methionine (IV
Table 1 and 2), while [13C6,15N4]arginine was the label incorporated at the lowest
rate in the polyamine pools (IV Supplementary Table 4). Nonetheless, each of
the labeled precursors reached levels close to its theoretical incorporation rate in
the control and MT-SSAT fibroblasts. With all three precursors, the control and
the MT-SSAT fibroblasts behaved in a similar fashion, while the SSATKO cells
incorporated slightly less label, especially during the [13C5,15N]methionine or
[13C5]ornithine treatments.
Theoretically,  the  analysis  of  the  flux  could  be  adapted  to  estimate  the
energy  consumption  in  each  cell  type.  If  we  consider  that  one  full  turn  of  the
polyamine cycle should consume four ATP equivalents (Figure 2) (Pirinen et al.,
2007; Cerrada-Gimenez et al., 2009) the following approximations could be used
for approximating the polyamine metabolism energy consumption: “the
synthesis  of  one pmol/µg DNA of  spermidine,  acetyl-spermidine,  spermine,  or
acetyl-spermine, consumes one pmol /µg DNA of ATP”.
However, there exists a small caveat in estimating these approximations.
During the polyamine flux studies the incorporation of the label provided by
each precursor into the polyamine pools followed a three phase process. In the
first phase, the label was poorly incorporated while the cell reservoirs of the
non-labeled precursor are being depleted. During the second phase, the label
was exponentially incorporated until reaching the maximum incorporation rate,
the third phase. Therefore, calculations to approximate the energy consumption
of each cell line can only be performed during the exponential phase of label
incorporation. If not, the calculations would be misleading.
The most crucial point in designing an experiment to follow the
polyamine flux was the time point selection. Polyamine flux is highly dependent
on the speed of the polyamine metabolism. The transgenic MT-SSAT fibroblasts
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with activated polyamine metabolism reached the maximum incorporation at 6
hours post treatment with [13C5,15N]methionine, and it was evident that for this
particular  cells  the  time  points  selected  (24,  48,  and  72h)  for  the  other  two
labeled precursors were well after the maximum incorporation time point. The
control cells reacted somewhat more slowly than the transgenic cells, while the
SSATKO fibroblasts were much slower at incorporating each of the labels.
Interestingly, when the [13C6,15N4]arginine  or  [13C5]ornithine treatments
were combined with the APAO inhibitor MDL 72,527 the levels of excreted
acetylated-spermidine were greatly increased in the control and MT-SSAT cells.
This together combined with the recent report indicating that the polyamine
exporter SLC3A2 colocalizes with SSAT in the plasma membrane of colon cancer
cells  (Uemura  et  al.,  2008)  supports  the  argument  that  the  SSAT  enzyme  is
needed for an efficient polyamine export from the cell.
 5.5 ALTERED INSULIN SECRETION
(UNPUBLISHED RESULTS)
The metallothionein promoter used in the MT-SSAT mouse line targeted the
transgene expression mainly to the pancreas and liver (Figure 6). The pancreas is
the organ that contains the largest pools of spermidine and spermine in the
mammalian body (Rosenthal and Tabor, 1956). Therefore, it was decided to
undertake a detailed study of the pancreas from the MT-SSAT transgenic mice.
Studies on how the same transgene construct could affect the development of
pancreatitis on transgenic rats have been previously published (Alhonen et al.,
2000; Hyvönen et al., 2007a) (see 2.6.4 ). However, due to the recent discovery
that activated polyamine catabolism could protect against the development of
insulin resistance (Niiranen et al., 2006; Pirinen et al., 2007; Cerrada-Gimenez et
al., 2009), it was also important to elucidate at how the increased polyamine
catabolism could affect insulin secretion.
In the intact pancreas and in pancreatic islets, the massive pancreatic
SSAT activation dramatically altered the polyamine pools. There was extensive
accumulation of putrescine, and acetylated spermidine, but the spermidine and
spermine pools decreased (Table 2). Morphologically the transgenic pancreas
did not differ from its non-transgenic counterpart. However, the detailed
analysis of the pancreatic islet composition did reveal a number of differences.
The transgenic animals had a 1.6-fold enlarged beta-cell area (non-transgenic:
0.0019 ± 0.0003; MT-SSAT: 0.0031 ± 0.0004; p = 0.032). Although the beta-cell area
was enlarged, no visible changes were seen in the alpha-cell area. Therefore, the
ratio of beta to alpha cells appeared 4-fold increased in the MT-SSAT transgenic
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mice. Moreover, the enlarged beta-cell area did not lead to greatly increased
pancreatic  insulin  levels.  On  the  contrary,  the  MT-SSAT  transgenic  mice  had
lower amounts of total pancreatic insulin (non-transgenic: 5.91 ± 0.21 pg
insulin/µg protein; MT-SSAT: 5.11 ± 0.37 pg insulin/µg protein; P = 0.11). This
was further confirmed when the gene expression of the two murine insulin
genes was analyzed.  Expression of  both Ins1 and Ins2 was reduced by 50 % in
the transgenic pancreatic islets.
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Table 2. Polyamine pools in the pancreas and pancreatic islets from
non-transgenic and MT-SSAT transgenic mice.
Polyamines are expressed as means ± SD of three animals per genotype. Statistical significance vs.
non-transgenic, * p < 0.05, ** p < 0.01  and *** p < 0.001.
Figure 9. Gene expression analysis from the pancreatic islets of the MT-SSAT
transgenic mice. The acidic ribosomal phosphoprotein P0 was used to normalize the
expression data. Data are expressed as mean ± SEM of three different pools of two to
three mice per pool. Data are transformed to the percentage of expression relative to the
non-transgenic expression (100 %). Values were statistically analyzed using Student’s
t-test. * p < 0.05, ** p <0.01 and *** p < 0.001.
Genotype
Putrescine Spermidine
N1-Ac
spermidine
Spermine
(pmol/µg DNA)
P
a
n
cr
e
a
s Non-transgenic ND 3932 ± 49           ND  866 ± 36
MT-SSAT       5200 ± 1169***         1166 ± 104*** 127 ± 103***        276 ± 50***
Is
le
ts Non-transgenic 39 ± 20   133.8 ± 44.7           ND  20 ± 4
MT-SSAT   318 ± 85**       40 ± 8.7* 106 ± 67***     12 ± 1*
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The expression level of Foxa2, which is one of the main transcription
factors  in  pancreatic  islets,  was  upregulated  in  the  MT-SSAT  transgenic
mice (2.7-fold). Foxa2 controls the expression of genes involved in
glucose-stimulated insulin secretion. The first step in glucose metabolism in
pancreatic islets is the glucose uptake, which is mediated through the Glut2
transporter.  The Glut2  gene expression was repressed by 67 % in the MT-SSAT
transgenic mice. Inside beta-cells, glucose enters the glycolytic pathway after its
phosphorylation into glucose-6-phosphate by Gck. Although Gck is believed to
be regulated by Foxa2, no changes were seen in the transcription level between
the two genotypes. Foxa2 negatively regulates the transcription factors HNF1?
and HNF4?, and in the transgenic line, the expression of both HNF1? and
HNF4? was greatly repressed (Figure 9). Insulin gene expression is positively
regulated by the transcription factor HNF1?, which appeared greatly
downregulated in the MT-SSAT mice. Therefore, the cascade initiated by the
upregulation of Foxa2 ended up regulating the expression of Ins1 and Ins2
through the HNF1? repression. This cascade is shown in Figure 10.
Figure 10. Schematic representation of the regulatory cascade of Foxa2 in the
MT-SSAT transgenic mice. Foxa2 negatively regulates (??) the expression of Glut2
and Gck, involved in the glucose stimulated insulin secretion; HNF1? and HNF4?
activate (??)the transcription of the two insulin genes (Ins1 and Ins2). Insulin then
inhibits Foxa2 through AKT phosphorylation.
The morphological and gene expression changes observed in the
transgenic pancreas were the impetus to analyze the pancreatic endocrine
function.  The insulin secretory patterns  were assayed by performing an in vivo
insulin release test (Figure 11). The glucose bolus had similar effects on both
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phenotypes, with the plasma glucose increasing steadily until 15 minutes and
decreasing afterwards (Figure 11). However, the insulin secretory patterns
appeared to be totally disrupted in the MT-SSAT transgenic mice. The expected
first peak of insulin secretion, which usually appears at two minutes, was clearly
seen in the non-transgenic animals but was clearly delayed in the MT-SSAT
transgenic mice (Figure 11). The insulin secretion peak in the MT-SSAT mice was
achieved at five minutes, and decreased thereafter. In contrast, in the
non-transgenic mice insulin secretion remained stable, slightly increasing until
the  end  of  the  experiment.  A  combination  of  the  results  in  the  insulin  and
glucose graphs revealed that the MT-SSAT mice were able to reduce the
circulating glucose levels similarly as the non-transgenic mice even though they
displayed a decreased and very disturbed insulin secretion.
Figure 11. In vivo insulin release test performed on four months old male
non-transgenic and MT-SSAT transgenic mice. Data are expressed as mean ± SEM
of ten mice per genotype. The continuous line represents the non-transgenic mice while
the broken line represents the MT-SSAT mice. Values were statistically analyzed using
Student’s t-test. *P < 0.05 and ***P < 0.001.
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 6 Discussion
Polyamines and their metabolic pathways have been known for a long time.
However, the complex relationship between polyamines and many basic cellular
functions has hampered the complete clarification of both the functions of
polyamines and how their metabolism is regulated. Polyamines have a wide
variety  of  actions,  e.g.  interactions  with  DNA,  RNA  and  proteins  (Jänne  et  al.,
2004). Polyamine homeostasis is tightly controlled to maintain precise
intracellular levels. Alterations in polyamine metabolism and in their
intracellular levels have been linked with many different disorders, such as
cancer (Gerner and Meyskens, 2004), pancreatitis (Alhonen et al., 2000) and
diabetes  (Pirinen  et  al.,  2007).  The  design,  production  and  phenotyping  of
transgenic mouse lines are a valuable asset for the polyamine researcher since it
helps to overcome these natural limitations. However, gaining new insights was
limited  by  the  state  of  the  art  techniques.  Therefore,  novel  techniques  for  the
synthesis of polyamine analogues and for studying the polyamine flux needed
to be developed.
I
Polyamine analogues have changed from being a group of therapeutic agents
that structurally resemble the basic polyamines into a group of compounds that
at the same time can be exploited for basic polyamine research (Casero and
Woster 2009). The ?-methylated compounds represent a subclass of polyamine
analogues that contain a methyl group at the ?-position of spermidine or
spermine chains. This subtype of polyamine analogues were first synthesized
during the mid 1980’s (Nagarajan and Ganem, 1986). The original synthetic
methods gave poor yields, making it difficult to obtain enough material to
perform in vivo studies (Lakanen et al., 1992). Therefore, improved synthetic
methods were needed. The new methods presented here allowed production of
?-methylspermidine, ?-methylspermine and bis-?-methylspermidine on the
gram scale. Additionally, the purity of the compounds obtained was good (99%).
Therefore, taking advantage of these new synthetic methods, it was possible to
design and test the different ?-methylated polyamines in vivo and in vitro. The in
vivo assays  were  performed  on  MT-SSAT  transgenic  mice  and  transgenic  rats,
while the in vitro assays were performed on fibroblasts isolated from MT-SSAT
rats.
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The three different analogues accumulated in the animal tissues in a dose
dependant manner, with ?-methylspermine having the highest toxicity both in
vivo and in vitro. Two known characteristics of ?-methylated polyamine
analogues are that they induce a depletion of the natural polyamine
pools (Lakanen et al., 1992) and that they are metabolically more stable than
their natural counterparts (Järvinen et al., 2005). The current results confirmed
both of these previous observations. ?-Methylspermidine was quite stable,
while the two spermine analogues appeared to be slowly catabolized into
?-methylspermidine. SMO was expected to be the responsible for the catabolism
of bis-?-methylspermine into ?-methylspermidine (Hyvönen et al., 2007b). In
vivo, all three analogues produced a decrease in hepatic spermidine and
spermine pools and a slight increase in the putrescine pool. However, SSAT was
not always induced by the analogue treatment. Treatment with
?-methylspermidine greatly induced the SSAT enzyme in both mouse lines and
in the three studied organs, liver, pancreas and kidney. ?-Methylspermine
affected  the  SSAT  activity  in  the  MT-SSAT  transgenic  mice.
Bis-?-methylspermine had barely any effect on SSAT. Nonetheless, the
alterations  seen  in  the  natural  polyamine  pools  argue  in  favor  of  SSAT  being
responsible for these changes. Moreover, the decreased levels of natural
spermidine and spermine were replaced by the accumulation of the analogues,
resulting in the fact that the total polyamine pools remained unaffected.
This  study  also  served  to  show  for  the  first  time  the  specificity  of  the
APAO enzyme for the R-isomer of acetylated-?-methylspermidine. Recently,
Hyvönen et al (2009) noted that the stereospecificity could play an important
role  in  the  regulation  of  ODC,  OAZ,  AdoMetDC  and  SSAT  expression  by  the
analogues. Moreover, the different isomers of the ?-methylspermidine
analogues were also proven to differently replace the natural polyamines in
their  common  functions,  such  as  the  formation  of  hypusine  (Hyvönen  et  al.,
2007b) and DNA condensation (Nayvelt et al., 2010).
II
The liver and the pancreas were the organs most affected by the MT-SSAT
transgene. The acute activation of polyamine catabolism had profound effects
on cellular metabolism. In order for the cells to survive and grow normally, they
need adequate polyamine levels, thus the MT-SSAT transgenic mice show a
compensatory activation of the polyamine biosynthesis (Suppola et al., 1999).
The activation of polyamine biosynthesis was reflected in the decreased hepatic
levels  of  AdoMet  and  ATP.  The  activated  polyamine  flux  in  the  MT-SSAT
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transgenic  mice  would  consume  AdoMet  in  the  form  of  dcAdoMet  for  the
spermidine  and  spermine  synthesis,  while  acetyl-CoA  would  be  used  for  their
catabolism. ATP is used as an energy source, both in the production of AdoMet
from methionine and the synthesis of cytosolic acetyl-CoA.
To  perform  an  analysis  of  the  hepatic  protein  expression  we  used  a
2D-PAGE approach. However, the 2D-PAGE technique is not devoid of
limitations. Analyzed proteins will be between 15kDa to 150-200KDa. Moreover,
the  analyzed  proteins  will  be  limited  to  those  present  on  a  detectable  amount,
and with an isoelectric point fitting the selected IPGs (Görg et al., 2009). Despite
this limitation, the 2D-PAGE coupled with MS protein detection is still a valid
proteomics technique. The 2D-PAGE analysis displayed relatively few
differences between the non-transgenic and the MT-SSAT mice. Only 21 proteins
were found to be differentially expressed between the two genotypes. Majority
of the differentially expressed proteins were directly involved in polyamine
and/or xenobiotic metabolism. However, it was quite unexpected that most of
the identified xenobiotic enzymes, such as catalase, GSTpi and carbonic
anhydrase III, were downregulated in the transgenic mice. It has previously
been hypothesized that increased polyamine catabolism elevates oxidative
stress  (Ha  et  al.,  1997).  The  elevated  oxidative  stress  would  be  caused  by  the
accumulation of hydrogen peroxide and 3-acetamidopropanal, the by-products
from the SSAT and APAO-catalyzed reactions. The fact that most of the
xenobiotic metabolizing enzymes were indeed repressed in the transgenic mice
was further confirmed by assaying their activities (II and III) and by the results
of a DNA microarray study (III). The DNA microarray results showed activation
of A170 stress-induced protein and cytoskeletal keratin 18, both of them
involved in the cellular response to oxidative stress (Ishii et al., 1996; Ku et al.,
1996). Therefore, although it was expected that there would be upregulation of
xenobiotic metabolizing enzymes in the transgenic mice, these enzymes were
actually found downregulated (discussed in greater detail in III).
The activated polyamine flux seen in the MT-SSAT transgenic mice
produced an increased energy demand. In accordance, the hepatic expression of
the 60-kDa heat-shock protein was increased in the transgenic mice. This protein
has been previously linked with an increased ATP recovery rate in rat cardiac
myocytes after ischemic injury (Lin et al., 2001). Similarly, the 60-kDa heat-shock
could  be  used  in  the  transgenic  animals  to  confer  protection  against  lowered
ATP levels due to activated polyamine flux.
The results of the proteomics study served to confirm that activation of
polyamine flux is linked with elevated PGC 1? expression as previously
detected by Pirinen et al. (2007; 2009). PGC 1? is a ubiquitous transcription
factor that links the transcription machinery with its energy state (Puigserver et
al., 2003). The expression of various identified proteins matched with the
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patterns found upon activation of PGC 1? or its targets. Moreover, the activation
of PPAR?, which is a known PGC 1? target (Vega et al., 2000), could be the
responsible for the lower GSTpi and selenium binding protein 2 seen in the
transgenic mouse line as shown in two different model of PPAR?
activation (Chu et al., 2004; Giometti et al., 2000).
In  conditions  of  low  energy  in  the  cells,  PGC  1? activates  the  three  key
enzymes of gluconeogenesis, PEPCK, fructose 1,6-bisphosphatase and
glucose-6-phosphatase (Yoon et al., 2001). In the transgenic mice, hepatic
expression of PEPCK and glucose-6-phosphatase were clearly induced already
in  the  fed  state.  The  combination  of  all  these  results  favorably  argues  for  the
activation  of  PGC  1? in  response  to  the  activated  polyamine  flux  in  the
MT-SSAT transgenic mice. Activation of hepatic gluconeogenesis by PGC 1? has
been linked with the development of T2D (Koo et al., 2004). However, it was
recently demonstrated that a transgenic mouse line harboring the SSAT gene
under  its  own  promoter  presented  elevated  PGC  1? expression  in  the  white
adipose tissue (Pirinen et al., 2007) and liver (Pirinen et al., 2009). This specific
mouse line represents an opposite phenotype to T2D, with enhanced insulin
sensitivity and glucose tolerance, similarly to the MT-SSAT transgenic mice.
Moreover, SSAT knockout mice show a completely opposite phenotype,
becoming insulin resistant upon ageing (Niiranen et al., 2006). Therefore,
overexpression of the SSAT gene produces phenotypic changes that protect the
organism against the development of T2D. Since the SSAT transgene was
overexpressed ubiquitously, it would be expected that ATP depletion would
occur  similarly  in  the  whole  organism.  Therefore,  the  general  lower  energy
levels would activate PGC 1? in all organs producing the particular phenotype
seen in the SSAT overexpressing mice.
III
The lifelong activation of polyamine catabolism, that the MT-SSAT transgenic
animals endure, produced a high level of oxidative stress, as reflected in the
13-fold elevated protein carbonyl content. In order to counteract the oxidative
stress, the transgenic mice would be anticipated to activate anti-oxidant
mechanisms. p53 is a transcription factor involved in the protection of the
organism against cellular damage. If there is oxidative stress then p53 becomes
active, and triggers a cascade aimed at the repair or elimination of damaged
cells (Matheu et al., 2008). The controlled activation of p53 helps the organism
repair/remove damaged cells and may lead to prolong the lifespan. However,
long-term activation of p53 causes to depletion of the stem cell pool and leads to
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accelerated aging (Matheu et al., 2008). Interestingly, p53 was found to be
greatly  activated  in  the  MT-SSAT  line.  Moreover,  a  long-term  survival  study
performed on the MT-SSAT mouse line revealed that the transgenic mice had a
50% reduced lifespan. In fact, the MT-SSAT mouse line shared several
similarities with another mouse model with activated p53
expression (p53+/m) (Tyner et al., 2002). Both lines present reduced lifespan,
reduced hair growth and decreased subcutaneous fat deposits. Moreover, both
lines are also resistant to tumor development (Pietilä et al., 2001). Therefore, the
chronic SSAT activation produced enhanced oxidative stress that lead to
activation of the p53 transcription factor as a measure to minimize the stress in
the transgenic mice concluding in an accelerated aging phenotype.
Not all effects of chronically activated p53 in the transgenic mice are
beneficial, with the exception of protection from tumor development. The
expression/activities of most of the antioxidant enzymes analyzed from the
MT-SSAT transgenic mice were decreased, such as GST pi, catalase, aldehyde
dehydrogenase, and CYP450 2E1. The decreased antioxidant capacity of the
MT-SSAT transgenic mice was associated to their accelerated aging (Semsei et
al., 1989; Brown-Borg and Rakoczy, 2000). Although decreased activity of the
various antioxidant enzymes was likely to have harmful effects, it had an
unexpected positive effect. The toxicity exhorted by many different
hepatotoxins, such as thioacetamide and carbon tetrachloride, appears after
their metabolization (Manibusan et al., 2007). Therefore, the low drug
metabolizing capability of the MT-SSAT transgenic mice helped to protect the
animals against these hepatotoxins.
IV
Previous methods to analyze polyamine flux were based on the use of unnatural
labeled polyamine precursors (fluoro-ornithine) and the analysis of the
incorporation  of  the  fluoro  label  into  the  polyamines  by  HPLC  (Kramer  et  al.,
2008). This combination does not invariably produce optimal results. Firstly, due
to the different biochemical properties of the natural and fluoro-labeled
polyamine it is not known how fluoro-ornithine could affect polyamine
metabolism. Secondly, the HPLC-based methodology is not able to separate
properly the natural and fluoro-labeled polyamines. The combination of labeled
natural precursors (13C and 13C, 15N)  with  a  newly  developed  LC/MS-MS
method (Häkkinen et al., 2008) allowed overcoming these problems. On one
hand, the labeled natural precursors ensured that polyamine metabolism was
not affected by their addition. On the other hand, the LC/MS-MS methodology
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allows for an efficient quantification of the labeled and natural polyamine pools.
Moreover, this method is highly versatile, having the appropriate standards, the
number of compounds to be analyzed can be easily increased.
The methodology was tested using three labeled polyamine precursors in
three different cell lines, non-transgenic, MT-SSAT and SSATKO cells. Of the
tested precursors, i.e. arginine, methionine and ornithine, arginine was
incorporated at the lowest rates. The lower arginine incorporation was probably
due to the dilution of the label with the unlabeled arginine present in the
growth media. The use of a methionine-free cell culture medium provided the
greater incorporation of the label derived from methionine.
Although the present methodology is an improvement over previous
HPLC-based methods (Kramer et al., 2008), the study of polyamine flux still
encounters some difficulties. The label incorporation starts with a phase of poor
incorporation, followed by an exponential phase until the incorporation reaches
a maximum or plateau phase. The analysis of the polyamine flux is only viable
during the second phase, the exponential phase. Once the label accumulation
reaches the maximum level (plateau phase), it is not possible to differentiate
whether  the  label  is  being  transferred  from  outside  the  cells  or  is  being
recirculated inside the polyamine metabolism. The time that each cell line needs
to reach the plateau phase of label incorporation depends on the particular cell
line  and  the  precursors  used.  Therefore,  extra  care  needs  to  be  taken  when
selecting the different time points for obtaining data. This point was particularly
obvious during the 13C5, 15N1-methionine treatment. At the 24 hours time point,
the non-transgenic and SSATKO cells were accumulating label in an exponential
manner, although the SSATKO cells were somewhat slower. However, the
MT-SSAT cells had already reached the plateau phase at the 6 hours time point.
The rate of label incorporation into the polyamine pools clearly showed that
polyamine  flux  speed  was  altered  according  to  the  level  of  SSAT
expression (MT-SSAT >> non-transgenic >> SSATKO). Moreover, the treatment
of the different cell lines with the APAO inhibitor MDL 72,527 clearly induced
export of acetylated polyamines in the non-transgenic and MT-SSAT cells.
Therefore,  similarly  as  with  the  polyamine  flux  speed,  the  export  rate  clearly
correlated with the level of SSAT activation.
Unpublished results
All previously published research related with studies on the MT-SSAT
transgenic mice and rats pancreas has focused on the exocrine aspect of it. When
the same transgene construct was activated using a non-toxic dose of a heavy
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metal in a MT-SSAT transgenic rat line, it greatly depleted the spermidine and
spermine pools, and the appearance of acute necrotizing pancreatitis
followed (Alhonen et al., 2000). The pancreatic structure suffered from
polyamine depletion, with the presence of autophagosomes and disruption of
intracellular membranes and organelles (Hyvönen et al., 2007a). Moreover,
pre-treatment with polyamine analogues, such as ?-methylspermidine or
bis-?-methylspermine, was able to prevent the onset of the symptoms (Räsänen
et al., 2002; Merentie et al., 2007). Therefore, considering that the pancreas is the
organ containing the largest spermidine pools (Rosenthal and Tabor, 1956) and
that the basal pancreatic SSAT activity was greatly activated in the MT-SSAT line
it  was  not  surprising  that  the  endocrine  pancreas  was  also  affected  by  the
transgene.
The MT-SSAT transgenic mice exhibited no signs of pancreatic
dysfunction other than the enlarged beta-cell area found. The alpha-cell area, as
well as the number of beta and alpha cells remained unchanged. Thus, the
enlargement of the beta-cell area was due to hypertrophy. Shantz et al (2001)
showed that the cardiac hypertrophy was caused by activating ODC. Moreover,
there  are  other  reports  about  the  effects  of  polyamines  on  hypertrophy  in
different organs, such as kidneys and heart (reviewed in Manteuffel-
Cymborowska 1993). Although the beta-cell area was enlarged in the MT-SSAT
transgenic mice, the total insulin level in the pancreas was decreased in the
transgenic mice. Thus, each transgenic beta-cell produced less insulin than their
non-transgenic counterparts did. It is not clear whether this is due to a reduced
insulin requirement in the insulin-sensitive transgenic mice or is attributable to
direct  regulation  of  insulin  production  by  polyamines  themselves.  In  fact,
polyamines tend to accumulate upon glucose stimuli. Hougaard et al (1986) and
Welsh (1990) observed a correlation between increased spermine levels and
elevated insulin transcription. In the MT-SSAT transgenic mice, the 70% reduced
islet spermine pool was accompanied by a slight reduction of insulin mRNA
and protein levels.
Polyamines have been localized in the cytoplasmic secretory granules
within the beta-cells (Hougaard et al., 1986). This suggests a function for
polyamines  in  the  insulin  secretory  mechanism.  Polyamines  may  be  substrates
for the Ca2+ responsive transglutaminase. Transglutaminases have been
implicated in the receptor-mediated endocytosis (Davies et al., 1980; Levitzki et
al., 1980) and directly linked with glucose-mediated insulin secretion (Gomis et
al., 1983; Lindsay et al., 1990). Therefore, the co-localization of polyamines,
insulin and transglutaminase in beta-cells suggest a common function for all of
them (Bungay et al., 1986).
Insulin secretion is biphasic, with the first peak of secretion taking place
in less than 5 minutes post-glucose load, followed by the second secretory phase
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that  lasts  for  20-30 minutes.  There  is  a  small  group of  granules  that  are  part  of
the immediately releasable pool that is responsible for the fist secretory phase.
The first phase peak is a K-ATP channel-dependent process, while the second
phase is regarded as being K-ATP channel-independent (Straub and Sharp,
2002). The insulin release test showed that while the non-transgenic mice
followed the expected biphasic pattern, the MT-SSAT transgenic mice showed a
single insulin secretion peak that reached its maximum at 5 minutes
post-glucose load and decreased steadily thereafter. However, although the
MT-SSAT transgenic mice presented a disturbed insulin secretion, their plasma
glucose was cleared from circulation much faster than in the non-transgenic
mice. Whether the altered insulin secretion observed in the MT-SSAT transgenic
mice  was  due  to  their  lower  insulin  levels/production,  or  the  direct  effect  of
polyamines  on  the  glucose-stimulated  insulin  secretion,  or  the  combination  of
the two is not known. Nonetheless, despite the badly disturbed insulin
secretion, the transgenic mice remained insulin-sensitive, clearing the glucose
bolus as fast as the non-transgenic mice.
As in the other of tissues where polyamine flux is activated, the pancreatic
islets from the MT-SSAT transgenic mice showed decreased ATP levels. During
low energy states, or fasting, the transcription factor Foxa2 is activated and this
controls hepatic gluconeogenesis (Zhang et al., 2005), fatty acid oxidation and
ketone body production (Wolfrum et al., 2004). In the pancreas, Foxa2 controls
the differentiation of primordial stem cells into alpha and beta-cells (Lee et al.,
2005). When phosphorilation of Foxa2 by the insulin-activated Akt occurs, Foxa2
is  excluded  from  the  nucleus  and  cannot  regulate  its  targets  (Wolfrum  et  al.,
2003). Moreover, Pirinen et al (2009) showed that hepatic activation of
polyamine flux repressed Akt and activated bile acid synthesis, which has been
shown  to  be  regulated  by  Foxa2  (Bochkis  et  al.,  2008).  Thus,  a  similar
mechanism  of  Foxa2  activation  in  the  MT-SSAT  transgenic  islets  could  occur,
where Foxa2 appeared to be upregulated. In confirmation, Foxa2 targets, such
as Glut2 (Lee et al., 2002), HNF1?, HNF4?, and Ins1 and 2 (Wang et al., 2002),
appeared  to  be  repressed  at  the  mRNA  level  in  the  MT-SSAT  transgenic  islets.
Moreover, Foxa2 is also involved in the glucose-dependent insulin
secretion (Friedman and Kaestner, 2006; Kitamura and Kitamura, 2007).
Therefore, the activated polyamine flux would induce the insulin-sensitivity
seen in the MT-SSAT transgenic mice through the constantly decreased energy
levels. The MT-SSAT insulin-sensitive mice had lower circulating insulin levels,
and thus, were not able to repress Foza2 via Akt-dependent phosphorylation.
Thus, the activated Foxa2 would repress insulin production and altering its
glucose-dependent secretion.
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 7 Summary and conclusions
The partial understanding of the polyamine metabolism and polyamine
functions drove the production of different transgenic rodent lines in order to
complete our understanding. The characterization of the MT-SSAT transgenic
mouse line, which represents activated polyamine catabolism, produced novel
information about the regulation of polyamine metabolism. This set of studies
on the polyamine biology in transgenic mouse models were performed using
novel techniques, such as improved polyamine analogue synthesis protocols,
proteomics and LC/MS-MS. This allowed expanding our initial knowledge in
different aspects of polyamine metabolism:
I.1 A  novel  methodology  for  producing  large  (gram)  quantities  of  the
?-methylated polyamine analogues was developed. The synthesis method
allowed  for  the  first  time  the in vivo testing of the ?-methylated polyamine
analogues.
I.2 The ?-methylated polyamine analogues were able at the same time
to activate the polyamine flux and substitute for the natural polyamine pools in
vivo. The analogues were non-toxic and metabolically more stable than natural
polyamines. Even thought, the two spermine analogues, ?-methylspermine and
bis-?-methylspermine, were catabolized into ?-methylspermidine.
II The  hepatic  protein  pattern  in  the  MT-SSAT  transgenic  mice
displayed the signs of activated polyamine catabolism. Moreover, the changes in
expression of some proteins indicated hepatic activation of the transcription
factor  PGC  1?.  However,  although  PGC  1? was  activated  in  the  liver,  the
MT-SSAT transgenic mice showed improved insulin sensitivity and glucose
tolerance.
III.1 Acute activation of the polyamine flux increased the oxidative
stress. Accordingly, the transcription factor p53 became activated, resulting in
accelerated aging in the transgenic mice.
III.2 Aging was accompanied with a reduction in xenobiotic
metabolizing enzymes activities, including catalase, aldehyde dehydrogenase,
and CYP450 2E1. The lower activities of these xenobiotic metabolizing enzymes
were associated with protecting the transgenic mice from hepatotoxic damage
such as treatment with thioacetamide or carbon tetrachloride.
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IV.1 The use of labeled natural polyamine precursors combined with the
LC/MS-MS method represented a major improvement over previous methods
for studying polyamine flux.
IV.2 Polyamine  flux  was  directly  correlated  with  the  levels  of  SSAT
activation. Moreover, efficient polyamine excretion needed the presence of the
SSAT enzyme.
V The MT-SSAT transgenic pancreas presented an enlarged beta-cell
area, and the transgenic animals showed an altered insulin secretion pattern.
Activation of the polyamine flux decreased the available ATP, the lower energy
content activated the transcription factor Foxa2. Activated Foxa2 in turn
controlled many different genes involved in the insulin production and the
glucose-stimulated insulin secretion pathways.
56
 8 References
Abate, N., Garg, A., Peshock, R.M., Stray-Gundersen, J., Grundy, S.M. (1995).
Relationships of generalized and regional adiposity to insulin sensitivity in men. J
Clin Invest 96(1): 88-98.
Aebi, H. 1984. Catalase in vitro. Methods Enzymol 105: 121-6.
de Alencastro, G., McCloskey, D. E., Kliemann, S. E., Maranduba, C. M. C., Pegg, A. E.,
Wang, X., Bertola, D. R., Schwartz, C.E, Passos-Bueno, M.R., Sertié, A.L. (2008). New
SMS mutation leads to a striking reduction in spermine synthase protein function
and a severe form of Snyder-Robinson X-linked recessive mental retardation
syndrome. J Med Genet 45(8): 539-543.
Alhonen, L., Parkkinen, J.J., Keinänen, T., Sinervirta, R., Herzig, K.H., Jänne J. (2000).
Activation of polyamine catabolism in transgenic rats induces acute pancreatitis.
Proc Natl Acad Sci USA 97(15): 8290-5.
Asher, G., Bercovich, Z., Tsvetkov, P., Shaul, Y., Kahana, C. (2005). 20S proteasomal
degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell 17(5): 645-
655.
Àvila, M.A., García-Trevijano, E.R., Lu, S.C., Corrales, F.J., Mato, J.M. (2004).
Methylthioadenosine. Int J Biochem Cell B 36(11): 2125-30.
Babbar, N., Murray-Stewart, T., Casero, R.A. (2007). Inflammation and polyamine
catabolism: the good, the bad and the ugly. Biochem Soc T 35(Pt 2): 300-304.
Babbar, N., Hacker, A., Huang, Y., Casero, R.A. (2006). Tumor necrosis factor alpha
induces spermidine/spermine N1-acetyltransferase through nuclear factor kappaB
in non-small cell lung cancer cells. J Biol Chem 281(34): 24182-24192.
Babbar, N., Ignatenko, N.A., Casero, R.A., Gerner, E.W. (2003). Cyclooxygenase-
independent induction of apoptosis by sulindac sulfone is mediated by polyamines
in colon cancer. J Biol Chem 278(48): 47762-75.
Bacchi, C.J., Nathan, H.C., Hutner, S.H., McCann, P.P., Sjoerdsma, A. (1980). Polyamine
metabolism: a potential therapeutic target in trypanosomes. Science 210(4467): 332-
334.
Bachrach, U., Bekierkunst, A., Abzug, S. (1967). The occurrence of putrescine, spermidine
and spermine in Ehrlich ascites cells. Israel J Med Sci 3(3): 474-477.
Bachrach, U., Heimer, Y.M. (1989). The Physiology of Polyamines. CRC Press.
Baker,  S.P.,  Grant,  P.A.  (2007).  The  SAGA  continues:  expanding  the  cellular  role  of  a
transcriptional co-activator complex. Oncogene 26(37): 5329-5340.
Balasundaram, D., Tyagi, A.K. (1991). Polyamine--DNA nexus: structural ramifications
and biological implications. Mol Cell Biochem 100(2): 129-40.
Becerra-Solano, L. E., Butler, J., Castañeda-Cisneros, G., McCloskey, D. E., Wang, X., Pegg,
A. E., Schwartz, C. E., Sánchez-Corona, J., García-Ortiz, J.E. (2009). A missense
mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-
Robinson syndrome. Am J Med Gen A 149A(3): 328-335.
Bello-Fernandez, C., Packham, G., Cleveland, J.L. (1993). The ornithine decarboxylase
gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA 90(16): 7804-7808.
57
Belting, M., Mani, K., Jönsson, M., Cheng, F., Sandgren, S., Jonsson, S., Ding, K., Delcors,
J.G., Fransson, L.A. (2003). Glypican-1 is a vehicle for polyamine uptake in
mammalian cells: a pivital role for nitrosothiol-derived nitric oxide. J  Biol  Chem
278(47): 47181-47189.
Benne, R., Hershey, J.W. (1978). The mechanism of action of protein synthesis initiation
factors from rabbit reticulocytes. J Biol Chem 253(9): 3078-3087.
Bercovich, Z., Kahana, C. (2004). Degradation of antizyme inhibitor, an ornithine
decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by
antizyme. J Biol Chem 279(52): 54097-54102.
Bochkis, I.M., Rubins, N.E., White, P., Furth, E.E., Friedman, J.R, Kaestner, K.H. (2008).
Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in
endoplasmic reticulum stress. Nat Med 14(8): 828-836.
Bolkenius, F.N., Seiler, N. (1981). Acetylderivatives as intermediates in polyamine
catabolism. Int J Biochem 13(3): 287-292.
Brieger, L. (1885). Ueber Ptomaine; Weitere Untersuchungen über Ptomaine; Untersuchungen
über Ptomaine. Berlin: August Hirschwald.
Brown-Borg, H.M., Rakoczy, S.G. (2000). Catalase expression in delayed and premature
aging mouse models. Exp Gerontol 35(2): 199-212.
Bungay, P.J., Owen, R.A., Coutts, I.C., Griffin, M. (1986). A role for transglutaminase in
glucose-stimulated insulin release from the pancreatic beta-cell. Biochem J 235(1):
269-278.
Bungay,  P.J.,  Potter,  J.M.,  Griffin,  M.  (1984).  A  role  for  polyamines  in  stimulus-secretion
coupling in the pancreatic beta-cell. Biosc Rep 4(10): 869-877.
Butcher, N.J., Broadhurst, G.M., Minchin, R.F. (2007). Polyamine-dependent regulation of
spermidine-spermine N1-acetyltransferase mRNA translation. J  Biol  Chem 282(39):
28530-28539.
Caldarera, C.M., Barbiroli, B., Moruzzi, G. (1965). Polyamines and nucleic acids during
development of the chick embryo. Biochem J 97(1): 84-88.
Casero, R.A., Pegg, A.E. (1993). Spermidine/spermine N1-acetyltransferase--the turning
point in polyamine metabolism. FASEB J 7(8): 653-61.
Casero, R.A., Marton, L.J. (2007). Targeting polyamine metabolism and function in cancer
and other hyperproliferative diseases. Nat Rev. Drug Discov 6(5): 373-90.
Casero, R.A., Woster, P.M. (2009). Recent advances in the development of polyamine
analogues as antitumor agents. J Med Chem 52(15): 4551-4573.
Cason, A. L., Ikeguchi, Y., Skinner, C., Wood, T. C., Holden, K. R., Lubs, H. A., Martinez,
F., Simensen, R.J., Stevenson, R.E., Pegg, A.E., Shcwartz, C.E. (2003). X-linked
spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur
J Hum Genet 11(12): 937-944.
Cerrada-Gimenez, M., Häyrinen, J., Juutinen, S., Reponen, T., Jänne, J., and Alhonen, L.
2009. Proteomic analysis of livers from a transgenic mouse line with activated
polyamine catabolism. Amino Acids. 38(2): 613-22.
Choi, W., Proctor, L., Xia, Q., Feng, Y., Gerner, E. W., Chiao, P. J., Hamilton, S. R., Zhang,
W. (2006). Inactivation of IkappaB contributes to transcriptional activation of
spermidine/spermine N1-acetyltransferase. Mol Carcinog 45(9): 685-693.
Chomczynski, P., Sacchi, N. (1987). Single-step method of RNA isolation by acid
58
guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162(1): 156-
159.
Chu, R., Lim, H., Brumfield, L., Liu, H., Herring, C., Ulintz, P., Reddy, J.K., Davison, M.
(2004). Protein profiling of mouse livers with peroxisome proliferator-activated
receptor alpha activation. Mol Cell Biol 24(14): 6288?6297.
Coffino, P. (2001). Regulation of cellular polyamines by antizyme. Nat Rev. Mol Cell Biol
2(3): 188-194.
Coleman, C.S., Pegg, A.E. (1997). Proteasomal degradation of spermidine/spermine N1-
acetyltransferase requires the carboxyl-terminal glutamic acid residues. J  Biol  Chem
272(18): 12164-12169.
Coleman, C.S., Stanley, B.A., Viswanath, R., Pegg, A.E. (1994). Rapid exchange of subunits
of mammalian ornithine decarboxylase. J Biol Chem 269(5): 3155-3158.
Coleman, C.S., Hu, G., Pegg, A.E. (2004). Putrescine biosynthesis in mammalian tissues.
Biochem J 379(Pt 3): 849-855.
Davies, P.J., Davies, D.R., Levitzki, A., Maxfield, F.R., Milhaud, P., Willingham, M.C,
Pastan, I.H. (1980). Transglutaminase is essential in receptor-mediated endocytosis
of alpha 2-macroglobulin and polypeptide hormones. Nature 283(5743): 162-167.
Duan, S.Z., Usher, M.G., Mortensen, R.M. (2009). PPARs: the vasculature, inflammation
and hypertension. Curr Opin Nephrol Hypertens 18(2): 128-133.
Dudley, H.W., Rosenheim, M.C., Rosenheim, O. (1924). The Chemical Constitution of
Spermine. I. The Isolation of Spermine from Animal Tissues, and the Preparation of
its Salts. Biochem J 18(6): 1263-1272.
Erdman, S.H., Ignatenko, N.A., Powell, M.B., Blohm-Mangone, K.A., Holubec, H.,
Guillén-Rodrígeuz, J.M., Gerner, E.W. (1999). APC-dependent changes in expression
of genes influencing polyamine metabolism, and consequences for gastrointestinal
carcinogenesis, in the Min mouse. Carcinogenesis 20(9): 1709-1713.
Farriol, M., Segovia-Silvestre, T., Venereo, Y., Orta, X. (2003). Antioxidant effect of
polyamines on erythrocyte cell membrane lipoperoxidation after free-radical
damage. Phytother Res 17(1): 44-47.
Fiori, L.M., Mechawar, N., Turecki, G. (2009). Identification and characterization of
spermidine/spermine N1-acetyltransferase promoter variants in suicide completers.
Biol Psychatry 66(5): 460-467.
Fogel-Petrovic, M., Kramer, D.L., Ganis, B., Casero, R.A., Porter, C.W. (1993). Cloning and
sequence analysis of the gene and cDNA encoding mouse spermidine/spermine N1-
acetyltransferase--a gene uniquely regulated by polyamines and their analogs.
Biochim Biophys Acta 1216(2): 255-264.
Fogel-Petrovic, M., Vujcic, S., Brown, P.J., Haddox, M.K., Porter, C.W. (1996). Effects of
polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-
spermine N1-acetyltransferase gene expression. Biochemistry 35(45): 14436-14444.
Folk, J.E., Park. M.H., Chung, S.I., Schrode, J., Lester, E.P., Cooper, H.L. (1980).
Polyamines as physiological substrates for transglutaminases. J  Biol  Chem 255(8):
3695-3700.
Friedman, J.R., Kaestner, K.H. (2006). The Foxa family of transcription factors in
development and metabolism. Cell Mol Life Sci 63(19-20): 2317-2328.
Fujita, K., Murakami, Y., Hayashi, S. (1982). A macromolecular inhibitor of the antizyme
59
to ornithine decarboxylase. Biochem J 204(3): 647-652.
Gandre, S., Bercovich, Z., Kahana, C. (2002). Ornithine decarboxylase-antizyme is rapidly
degraded through a mechanism that requires functional ubiquitin-dependent
proteolytic activity. Eur J Biochem 269(4): 1316-1322.
Gerner, E.W., Meyskens, F.L. (2004). Polyamines and cancer: old molecules, new
understanding. Nat Rev Cancer 4(10): 781-792.
Gimelli, G.., Giglio, S., Zuffardi, O., Alhonen, L. Suppola, S., Cusano, R., Lo Nigro, C.,
Gatti, R, Ravazzolo, R., Seri, M. (2002). Gene dosage of the spermidine/spermine N1-
acetyltransferase  (SSAT)  gene  with  putrescine  accumulation  in  a  patient  with  a
Xp21.1p22.12 duplication and keratosis follicularis spinulosa decalvans (KFSD).
Hum Genet 111(3): 235-241.
Giometti, C. S., Liang, X., Tollaksen, S. L., Wall, D. B., Lubman, D. M., Subbarao, V., Rao,
M. S. (2000). Mouse liver selenium-binding protein decreased in abundance by
peroxisome proliferators. Electrophoresis 21(11): 2162?2169.
Gomis, R., Sener, A., Malaisse-Lagae, F., Malaisse, W.J. (1983). Transglutaminase activity
in pancreatic islets. Biochim Biophys Acta 760(3): 384-388.
Gotoh, M., Maki, T., Kiyoizumi, T., Satomi, S., Monaco, A.P. (1985). An improved method
for isolation of mouse pancreatic islets. Transplantation 40(4): 437-438.
Granger, J., Remick, D. (2005). Acute pancreatitis: models, markers, and mediators. Shock
24 Suppl 1: 45-51.
Guipponi, M., Deutsch, S., Kohler, K., Perroud, N., Le Gal, F., Vessaz, M., Laforge, T.,
Petit, B., Jollant, F., Guillaume, S., Baud., P., Courtet, P., La Harpe, R., Malafosse, A.
(2008). Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal
behavior. Am J Med Genet B Neuropsychiatr Genet 150B(6): 799-807
Görg, A., Drews, O., Lück, C., Weiland, F., Weiss, W. (2009). 2-DE with IPGs.
Electrophoresis 30 Suppl 1: S122-132.
Ha, H.C., Sirisoma, N.S., Kuppusame, P., Zweier, J.L., Woster, P.M., Casero, R.A. (1998).
The natural polyamine spermine functions directly as a free radical scavenger. Proc
Natl Acad Sci USA 95(19): 11140-11145.
Ha, H.C., Woster, P.M., Yager, J.D., Casero, R.A. (1997). The role of polyamine catabolism
in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci USA
94(21): 11557-11562.
Ha, S.C., Lowenhaupt, K., Rich, A., Kim, Y., Kim, K.K. (2005). Crystal structure of a
junction between B-DNA and Z-DNA reveals two extruded bases. Nature 437(7062):
1183-1186.
Hamana, K., Matsuzaki, S. (1992). Polyamines as a chemotaxonomic marker in bacterial
systematics. Crit Rev Microbiol 18(4): 261-83.
Handschin, C., Lin, J., Rhee, J., Peyer, A.K., Chin, S., Wu, P.H., Meyer, U.A., Spiegelman,
B.M. (2005). Nutritional regulation of hepatic heme biosynthesis and porphyria
through PGC-1alpha. Cell 122(4): 505-15.
He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J.
Vogelstein,  B.,  Kinzler,  K.W. (1998).  Identification of c-MYC as a target of the APC
pathway. Science 281(5382): 1509-1512.
Heby, O. (1981). Role of polyamines in the control of cell proliferation and differentiation.
Differentiation 19(1), 1-20.
60
Heby, O., Persson, L., Rentala, M. (2007). Targeting the polyamine biosynthetic enzymes:
a promising approach to therapy of African sleeping sickness, Chagas' disease, and
leishmaniasis. Amino Acids 33(2): 359-366.
Heby, O., Roberts, S.C., Ullman, B. (2003). Polyamine biosynthetic enzymes as drug
targets in parasitic protozoa. Biochem Soc T 31(2): 415-419.
Heller,  J.S.,  Fong,  W.F.,  Canellakis,  E.S.  (1976).  Induction  of  a  protein  inhibitor  to
ornithine decarboxylase by the end products of its reaction. Proc Natl Acad Sci USA
73(6): 1858-1862.
Hernández, S.M., Sánchez, M.S., de Tarlovsky, M.N.S. (2006). Polyamines as a defense
mechanism against lipoperoxidation in Trypanosoma cruzi. Acta Trop 98(1): 94-102.
Herzig, K.H., Jänne, J., Alhonen, L. (2005). Acute pancreatitis induced by activation of the
polyamine catabolism in gene-modified mice and rats overexpressing
spermidine/spermine N1-acetyltransferase. Scand J Gastroenterol 40(1): 120-121.
Hill, J.R., Morris, D.R. (1992). Cell-specific translation of S-adenosylmethionine
decarboxylase mRNA. Regulation by the 5' transcript leader. J  Biol  Chem 267(30):
21886-21893.
Hougaard, D.M., Nielsen, J.H., and Larsson, L.I. 1986. Localization and biosynthesis of
polyamines in insulin-producing cells. Biochem J 238(1): 43-7.
Hyvönen, M. T., Merentie, M., Uimari, A., Keinänen, T. A., Jänne, J., Alhonen, L. (2007a).
Mechanisms of polyamine catabolism-induced acute pancreatitis. Biochem  Soc  T
35(Pt 2): 326-330.
Hyvönen, M. T., Keinänen, T. A., Cerrada-Gimenez, M., Sinervirta, R., Grigorenko, N.,
Khomutov, A. R., Vepsäläinen, J., Alhonen, L., Jänne, J. (2007b). Role of hypusinated
eukaryotic translation initiation factor 5A in polyamine depletion-induced
cytostasis. J Biol Chem 282(48): 34700?34706.
Hyvönen, M., Howard, M., Anderson, C., Grigorenko, N., Khomutov, A., Vepsäläinen, J.,
Alhonen, L., Jänne, J., Keinänen, T. (2009). Divergent regulation of the key enzymes
of polyamine metabolism by chiral alpha-methylated polyamine analogs. Biochem J.
422(2):321-8.
Hyvönen, M. T., Herzig, K., Sinervirta, R., Albrecht, E., Nordback, I., Sand, J., Keinänen,
T. A., Vepsäläinen, J., Grigorenko, N., Khomutov, A.R., Krüger, B., Jänne, J.,
Alhonen, L. (2006). Activated polyamine catabolism in acute pancreatitis: alpha-
methylated polyamine analogues prevent trypsinogen activation and pancreatitis-
associated mortality. Am J Pathol 168(1): 115-122.
Hyvönen, M. T., Uimari, A., Keinänen, T. A., Heikkinen, S., Pellinen, R., Wahlfors, T.,
Korhonen, A., Närvänen, A., Wahlfors, J., Alhonen, L. Jänne, J. (2006). Polyamine-
regulated unproductive splicing and translation of spermidine/spermine N1-
acetyltransferase. RNA 12(8): 1569-1582.
Hyvönen, M.T., Keinänen, T.A., Khomutov, A.R., Khomutov, R.M., Eloranta, T.O. (1992).
Monitoring of the uptake and metabolism of aminooxy analogues of polyamines in
cultured cells by high-performance liquid chromatography. J Chromatogr 574(1): 17-
21.
Häkkinen, M. R., Keinänen, T. A., Vepsäläinen, J., Khomutov, A. R., Alhonen, L., Jänne, J.,
and Auriola, S. 2008. Quantitative determination of underivatized polyamines by
using isotope dilution RP-LC-ESI-MS/MS. J Pharm Biomed Anal 48(2): 414-21.
61
Hölttä, E. (1977). Oxidation of spermidine and spermine in rat liver: purification and
properties of polyamine oxidase. Biochemistry 16(1): 91-100.
Hölttä, E., Sinervirta, R., Jänne, J. (1973). Synthesis and accumulation of polyamines in rat
liver regenerating after treatment with carbon tetrachloride. Biochem Biophys Res
Commun 54(1): 350-357.
Ignatenko, N.A., Babbar, N., Mehta, D., Casero, R.A., Gerner, E.W. (2004). Suppression of
polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol Carcinog
39(2): 91-102.
Ishii, T., Yanagawa, T., Kawane, T., Yuki, K., Seita, J., Yoshida, H., Bannai, S. (1996).
Murine peritoneal macrophages induce a novel 60-kDa protein with structural
similarity to a tyrosine kinase p56lck-associated protein in response to oxidative
stress. Biochem Biophys Res Commun 226(2): 456-460.
Ivanov, I.P., Rohrwasser, A., Terreros, D.A., Gesteland, R.F., Atkins, J.F. (2000). Discovery
of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3.
Proc Natl Acad Sci USA 97(9): 4808-4813.
Iyer, R.K., Kim, H.K., Tsoa, R.W., Grody, W.W., Cederbaum, S.D. (2002). Cloning and
characterization of human agmatinase. Mol Genet Metab 75(3): 209-218.
Jell, J., Merali, S., Hensen, M. L., Mazurchuk, R., Spernyak, J. A., Diegelman, P., Kisiel, N.
D., Barrero, C., Deeb, K.K., Alhonen, L., Patel, M.S., Porter, C.W. (2007). Genetically
altered expression of spermidine/spermine N1-acetyltransferase affects fat
metabolism in mice via acetyl-CoA. J Biol Chem 282(11): 8404?8413.
Jin, H., Lamsa, T., Merentie, M., Hyvonen, M. T., Sand, J., Raty, S., Herzig, K.H., Alhonen,
L., Nordback, I. (2008). Polyamine levels in the pancreas and the blood change
according to the severity of pancreatitis. Pancreatology 8(1): 15-24.
Johnson, T.D. (1996). Modulation of channel function by polyamines. Trends Pharmacol Sci
17(1): 22-27.
Jänne, J., Williams-Ashman, H.G. (1971). On the purification of L-ornithine decarboxylase
from rat prostate and effects of thiol compounds on the enzyme. J Biol Chem 246(6):
1725-32.
Jänne, J., Alhonen, L., Keinänen, T. A., Pietilä, M., Uimari, A., Pirinen, E., Hyvönen, M. T.,
Järvinen, A. (2005). Animal disease models generated by genetic engineering of
polyamine metabolism. J Cell Mol Med 9(4): 865-82.
Jänne, J., Alhonen, L., Pietilä, M., Keinänen, T.A. (2004). Genetic approaches to the
cellular functions of polyamines in mammals. Eur J Biochem 271(5): 877-894.
Järvinen, A., Grigorenko, N., Khomutov, A. R., Hyvönen, M. T., Uimari, A., Vepsäläinen,
J., Sinervirta, R., Keinänen, T.A., Vujcic, S., Alhonen, L., Porter, C.W., Jänne J. (2005).
Metabolic stability of alpha-methylated polyamine derivatives and their use as
substitutes for the natural polyamines. J Biol Chem 280(8): 6595-6601.
Kahana, C. (2007). Ubiquitin dependent and independent protein degradation in the
regulation of cellular polyamines. Amino Acids 33(2): 225-230.
Kanerva, K., Lappalainen, J., Mäkitie, L. T., Virolainen, S., Kovanen, P. T., Andersson, L.
C. (2009). Expression of antizyme inhibitor 2 in mast cells and role of polyamines as
selective regulators of serotonin secretion. PloS ONE 4(8): e6858.
Kitamura, T., Kitamura, I. (2007). Role of FoxO Proteins in Pancreatic beta Cells. Endocr J
54(4): 507-515.
62
Kleinig, T.J., Vink, R. (2009). Suppression of inflammation in ischemic and hemorrhagic
stroke: therapeutic options. Curr Opin Neurol 22(3): 294-301.
Koo, S., Satoh, H., Herzig, S., Lee, C., Hedrick, S., Kulkarni, R., Evans, R. M., Olefksy, J.,
Montminy, M. (2004). PGC-1 promotes insulin resistance in liver through PPAR-
alpha-dependent induction of TRB-3. Nat Med 10(5): 530-4.
Kramer, D. L., Diegelman, P., Jell, J., Vujcic, S., Merali, S., Porter, C. W. (2008). Polyamine
acetylation modulates polyamine metabolic flux, a prelude to broader metabolic
consequences. J Biol Chem 283(7): 4241-4251.
Ku, N. O., Michie, S. A., Soetikno, R. M., Resurreccion, E. Z., Broome, R. L., Oshima, R.
G., Omary, M. B. (1996). Susceptibility to hepatotoxicity in transgenic mice that
express a dominant-negative human keratin 18 mutant. J Clin Invest 98(4): 1034-
1046.
Laakso, M. (2001). Insulin resistance and its impact on the approach to therapy of type 2
diabetes. Int J Clin Pract Suppl (121): 8-12.
Lakanen, J.R., Coward, J.K., Pegg, A.E. (1992). alpha-Methyl polyamines: metabolically
stable spermidine and spermine mimics capable of supporting growth in cells
depleted of polyamines. J Med Chem 35(4): 724?34.
Lee, C.S., Sund, N.J., Behr, R., Herrera, P.L., Kaestner, K.H. (2005). Foxa2 is required for
the differentiation of pancreatic alpha-cells. Dev Biol 278(2): 484-495.
Lee, C. S., Sund, N. J., Vatamaniuk, M. Z., Matschinsky, F. M., Stoffers, D. A., Kaestner, K.
H. (2002). Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo.
Diabetes 51(8): 2546-2551.
van Leeuwenhoek, A.P. (1678). Observationes D. Anthonii Leeuwenhoek, de Natis e
semine genital Animalculis. Philos Trans R Soc London 12: 1040-1043.
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., Ahn, B. W.,
Shaltiel, S., Stadtman, E.R. (1990). Determination of carbonyl content in oxidatively
modified proteins. Methods Enzymol 186: 464-478.
Levitzki, A., Willingham, M., Pastan, I. (1980). Evidence for participation of
transglutaminase in receptor-mediated endocytosis. Proc  Natl  Acad  Sci  USA 77(5):
2706-2710.
Li,  X.,  Coffino,  P.  (1993).  Degradation  of  ornithine  decarboxylase:  exposure  of  the  C-
terminal target by a polyamine-inducible inhibitory protein. Mol Cell Biol 13(4):
2377-2383.
Libby, P.R. (1978). Calf liver nuclear N-acetyltransferases. Purification and properties of
two enzymes with both spermidine acetyltransferase and histone acetyltransferase
activities. J Biol Chem 253(1): 233-237.
Libby, P.R. (1980). Rat liver nuclear N-acetyltransferases: Separation of two enzymes with
both histone and spermidine acetyltransferase activity. Arch Biochem Biophys 203(1):
384-389.
Lin,  K.  M.,  Lin,  B.,  Lian,  I.  Y.,  Mestril,  R.,  Scheffler,  I.  E.,  Dillmann,  W.  H.  (2001).
Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac
myocytes protects mitochondrial function and prevents apoptotic cell deaths
induced by simulated ischemia-reoxygenation. Circulation 103(13): 1787?1792.
Lindsay, M.A., Bungay, P.J., Griffin, M. (1990). Transglutaminase involvement in the
secretion of insulin from electropermeabilised rat islets of Langerhans. Biosci Rep
63
10(6): 557-561.
Lipowsky, G., Bischoff, F. R., Schwarzmaier, P., Kraft, R., Kostka, S., Hartmann, E., Kutay,
U.,  Görlich, D. (2000).  Exportin 4:  a mediator of a novel nuclear export pathway in
higher eukaryotes. EMBO J 19(16): 4362-4371.
Liu, L.F., Wang, J.C. (1987). Supercoiling of the DNA template during transcription. Proc
Natl Acad Sci USA 84(20): 7024-7027.
López-Contreras, A.J., López-Garcia, C., Jiménez-Cervantes, C., Cremades, A., Peñafiel,
R. (2006). Mouse ornithine decarboxylase-like gene encodes an antizyme inhibitor
devoid of ornithine and arginine decarboxylating activity. J  Biol  Chem 281(41):
30896-30906.
Lortie, M. J., Novotny, W. F., Peterson, O. W., Vallon, V., Malvey, K., Mendonca, M.,
Satriano,  J.,  Insel,  P.,  Thomson,  S.C.,  Blantz,  R.C.  (1996).  Agmatine,  a  bioactive
metabolite of arginine. Production, degradation, and functional effects in the kidney
of the rat. J Clin Invest 97(2): 413-420.
Malumbres, M., Barbacid, M. (2009). Cell cycle, CDKs and cancer: a changing paradigm.
Nat Rev Cancer 9(3): 153-166.
Mangold, U. (2005). The antizyme family: polyamines and beyond. IUBMB Life 57(10):
671-676.
Manibusan, M.K., Odin, M., Eastmond, D.A. (2007). Postulated carbon tetrachloride
mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 25(3):
185-209.
Manteuffel-Cymborowska, M. (1993). Differential role of polyamines in hyperplasia and
hypertrophy. Acta Biochim Pol 40(3): 383-388.
Manzella, J.M., Rychlik, W., Rhoads, R.E., Hershey, J.W., Blackshear, P.J. (1991). Insulin
induction of ornithine decarboxylase. Importance of mRNA secondary structure
and phosphorylation of eucaryotic initiation factors eIF-4B and eIF-4E. J  Biol  Chem
266(4): 2383-2389.
Matheu, A., Maraver, A., Serrano, M. (2008). The Arf/p53 pathway in cancer and aging.
Cancer Res 68(15): 6031-6034.
Matsufuji, S., Matsufuji, T., Miyazaki, Y., Murakami, Y., Atkins, J. F., Gesteland, R. F.,
Hayashi, S. (1995). Autoregulatory frameshifting in decoding mammalian ornithine
decarboxylase antizyme. Cell 80(1): 51-60.
Matsui,  I.,  Pegg,  A.E.  (1981).  Effect  of  inhibitors  of  protein  synthesis  on  rat  liver
spermidine N-acetyltransferase. Biochim Biophys Acta 675(3-4): 373-378.
McCarthy, M.I., Zeggini, E. (2009). Genome-wide association studies in type 2 diabetes.
Curr Diab Rep 9(2): 164-171.
McCloskey, D.E., Pegg, A.E. (2000). Altered spermidine/spermine N1-acetyltransferase
activity as a mechanism of cellular resistance to bis(ethyl)polyamine analogues. J
Biol Chem 275(37): 28708-28714.
Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature 454(7203):
428-435.
Merentie, M., Uimari, A., Pietilä, M., Sinervirta, R., Keinänen, T. A., Vepsäläinen, J.,
Khomutov, A., Grigorenko, N., Herzig, K.H., Jänne, J., Alhonen, L. (2007). Oxidative
stress and inflammation in the pathogenesis of activated polyamine catabolism-
induced acute pancreatitis. Amino Acids 33(2): 323-30.
64
Metcalf, B. W., Bey, P., Danzin, C., Jung, M. J., Casara, P., Vevert, J. P. (1978). Catalytic
irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by
substrate and product analogs. J Am Chem Soc 100(8): 2551-2553.
Mitchell,  J.L.A.,  Thane,  T.K.,  Sequeira,  J.M.,  Thokala,  R.  (2007).  Unusual  aspects  of  the
polyamine  transport  system  affect  the  design  of  strategies  for  use  of  polyamine
analogues in chemotherapy. Biochem Soc Trans 35(Pt 2): 318-321.
Morgan, J.E., Blankenship, J.W., Matthews, H.R. (1987). Polyamines and acetylpolyamines
increase the stability and alter the conformation of nucleosome core particles.
Biochemistry 26(12): 3643-3649.
Mudd, S.H., Poole, J.R. (1975). Labile methyl balances for normal humans on various
dietary regimens. Metab Clin Exp 24(6): 721-735.
Murakami, Y., Ichiba, T., Matsufuji, S., Hayashi, S. (1996). Cloning of antizyme inhibitor, a
highly homologous protein to ornithine decarboxylase. J  Biol  Chem 271(7): 3340-
3342.
Murakami, Y., Matsufuji, S., Kameji, T., Hayashi, S., Igarashi, K., Tamura, T., Tanaka, K.,
Ichihara, A. (1992). Ornithine decarboxylase is degraded by the 26S proteasome
without ubiquitination. Nature 360(6404): 597?599.
Murray-Stewart, T., Wang, Y., Devereux, W., Casero, R.A. (2002). Cloning and
characterization of multiple human polyamine oxidase splice variants that code for
isoenzymes with different biochemical characteristics. Biochem J 368(Pt 3): 673-677.
Nagarajan, S., Ganem, B. (1986). Chemistry of naturally occurring polyamines. 10.
Nonmetabolizable derivatives of spermine and spermidine. J Org Chem 51(25): 4856-
4861.
Nayvelt, I., Hyvönen, M. T., Alhonen, L., Pandya, I., Thomas, T., Khomutov, A. R.,
Vepsäläinen, J., Patel, R, Keinänen, T.A., Thomas, T.J. (2010). DNA condensation by
chiral alpha-methylated polyamine analogues and protection of cellular DNA from
oxidative damage. Biomacromolecules 11(1): 97-105.
van Nieuwenhove, S., Schechter, P. J., Declercq, J., Boné, G., Burke, J., Sjoerdsma, A.
(1985).  Treatment  of  gambiense  sleeping  sickness  in  the  Sudan  with  oral  DFMO
(DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first
field trial. Trans R Soc Trop Med Hyg 79(5): 692-698.
Niiranen, K., Keinänen, T. A., Pirinen, E., Heikkinen, S., Tusa, M., Fatrai, S., Suppola, S.,
Pietilä, M., Uimari, A., Laakso, M., Alhonen, L., Jänne, J. (2006). Mice with targeted
disruption of spermidine/spermine N1-acetyltransferase gene maintain nearly
normal  tissue  polyamine  homeostasis  but  show  signs  of  insulin  resistance  upon
aging. J Cell Mol Med 10(4): 933-945.
O'Brien,  T.G.,  Simsiman,  R.C.,  Boutwell,  R.K.  (1975).  Induction  of  the  polyamine-
biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res
35(7): 1662-1670.
Oredsson, S.M. (2003). Polyamine dependence of normal cell-cycle progression. Biochem
Soc T 31(2): 366-370.
Packham, G., Cleveland, J.L. (1997). Induction of ornithine decarboxylase by IL-3 is
mediated by sequential c-Myc-independent and c-Myc-dependent pathways.
Oncogene 15(10): 1219-1232.
Park, M.H. (1989). The essential role of hypusine in eukaryotic translation initiation factor
65
4D (eIF-4D). Purification of eIF-4D and its precursors and comparison of their
activities. J Biol Chem 264(31): 18531-18535.
Park, M.H., Cooper, H.L., Folk, J.E. (1982). The biosynthesis of protein-bound hypusine
(N epsilon -(4-amino-2-hydroxybutyl)lysine). Lysine as the amino acid precursor
and the intermediate role of deoxyhypusine (N epsilon -(4-aminobutyl)lysine). J Biol
Chem 257(12): 7217-7222.
Passonneau, J.V., Lowry, O.H. (1993). Enzymatic analysis: A practical guide. Humana Press
Pavlovic, D. D., Uzunova, P., Galabova, T., Peneva, V., Sokolova, Z., Bjelakovic, G.,
Ribarov, S. (1992). Polyamines as modulators of lipoperoxidation. Gen Physiol
Biophys 11(2): 203-211.
Pegg, A. E., Kameji, T., Shirahata, A., Stanley, B., Madhubala, R., Pajunen, A. (1988).
Regulation of mammalian S-adenosylmethionine decarboxylase. Adv Enzyme Regul
27: 43-55.
Pegg, A.E. (2008). Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator.
Am J Physiol Endocrinol Metab 294(6): E995-1010.
Pegg, A.E., Williams-Ashman, H.G. (1969). On the role of S-adenosyl-L-methionine in the
biosynthesis of spermidine by rat prostate. J Biol Chem 244(4): 682-693.
Pérez-Cano, F.J., Franch, A., Castellote, C., Castell, M. (2003). Immunomodulatory action
of spermine and spermidine on NR8383 macrophage line in various culture
conditions. Cell Immunol 226(2): 86-94.
Persson, L., Pegg, A.E. (1984). Studies of the induction of spermidine/spermine N1-
acetyltransferase using a specific antiserum. J Biol Chem 259(20): 12364-12367.
Pietilä, M., Alhonen, L., Halmekytö, M., Kanter, P., Jänne, J., Porter, C. W. (1997).
Activation of polyamine catabolism profoundly alters tissue polyamine pools and
affects hair growth and female fertility in transgenic mice overexpressing
spermidine/spermine N1-acetyltransferase. J Biol Chem 272(30): 18746-18751.
Pietilä, M., Parkkinen, J.J., Alhonen, L., Jänne, J. (2001). Relation of skin polyamines to the
hairless phenotype in transgenic mice overexpressing spermidine/spermine N-
acetyltransferase. J Invest Dermatol 116(5): 801-805.
Pirinen, E., Gylling, H., Itkonen, P., Yaluri, N., Heikkinen, S., Pietilä, M., Kuulasmaa, T.,
Tusa, M., Cerrada-Gimenez, M., Pihlajamäki, J., Alhonen, L., Jänne, J., Miettinen, T.,
Laakso, M. (2009). Activated polyamine catabolism leads to low cholesterol levels
by enhancing bile acid synthesis. Amino Acids 38(2):549-60.
Pirinen, E., Kuulasmaa, T., Pietilä, M., Heikkinen, S., Tusa, M., Itkonen, P., Boman, S.,
Skommer, J., Virkamäki, A., Hohtola, E., Kettunen, M., Fatrai, S., Kansanen, E.,
Koota, S., Niiranen, K., Parkkinen, J., Levonen, A.L., Ylä-Herttuala, S., Hiltunen,
J.K., Alhonen, L., Smith, U., Jänne, J., Laakso, M. (2007). Enhanced polyamine
catabolism  alters  homeostatic  control  of  white  adipose  tissue  mass,  energy
expenditure, and glucose metabolism. Mol Cell Biol 27(13): 4953-67.
Pitkänen, L.T., Heiskala, M., Andersson, L.C. (2001). Expression of a novel human
ornithine decarboxylase-like protein in the central nervous system and testes.
Biochem Biophys Res Commun 287(5): 1051-1057.
Poulin, R., Zhao, C., Verma, S., Charest-Gaudreault, R., Audette, M. (1998). Dependence
of mammalian putrescine and spermidine transport on plasma-membrane
potential: identification of an amiloride binding site on the putrescine carrier.
66
Biochem J 330 ( Pt 3): 1283-1291.
Puigserver, P., Spiegelman, B.M. (2003). Peroxisome proliferator-activated receptor-
gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic
regulator. Endoc Rev 24(1): 78-90.
Qin, C., Samudio, I., Ngwenya, S., Safe, S. (2004). Estrogen-dependent regulation of
ornithine decarboxylase in breast cancer cells through activation of nongenomic
cAMP-dependent pathways. Mol Carcinog 40(3): 160-170.
Raina, A., Jänne, J. (1968). Biosynthesis of putrescine: characterization of ornithine
decarboxylase from regenerating rat liver. Acta Chem Scand 22(7): 2375-2378.
Rakoff-Nahoum, S. (2006). Why cancer and inflammation? Yale J Biol Med 79(3-4): 123-130.
Ray, A., Huisman, M. V., Tamsma, J. T., van Asten, J., Bingen, B. O., Broeders, E. A. B. J.,
Hoogeveen, E. S., van Hout, F., Kwee, V.A., Laman, B., Malgo, F., Mohammadi, M.,
Nijenhuis, M., Rijkée, M., van TEllingen, M.M., Tromp, M., Tummers, Q., de Vries,
L. (2009). The role of inflammation on atherosclerosis, intermediate and clinical
cardiovascular endpoints in type 2 diabetes mellitus. Eur J Intern Med 20(3): 253-260.
Regunathan, S., Reis, D.J. (2000). Characterization of arginine decarboxylase in rat brain
and liver: distinction from ornithine decarboxylase. J Neurochem 74(5): 2201-2208.
Rhodes, C.J. (2005). Type 2 diabetes-a matter of beta-cell life and death? Science 307(5708):
380-384.
Rosenthal, S.M., Tabor, C.W. (1956). The pharmacology of spermine and spermidine;
distribution and excretion. J Pharmacol Exp Ther 116(2): 131-138.
Ruan, H., Shantz, L.M., Pegg, A.E., Morris, D.R. (1996). The upstream open reading frame
of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-
responsive translational control element. J Biol Chem 271(47): 29576-29582.
Ruhl, M., Himmelspach, M., Bahr, G. M., Hammerschmid, F., Jaksche, H., Wolff, B.,
Aschauer,  H.,  Farrington,  G.K.,  Probst,  H.  Bevec,  D.  (1993).  Eukaryotic  initiation
factor  5A  is  a  cellular  target  of  the  human  immunodeficiency  virus  type  1  Rev
activation domain mediating trans-activation. J Cell Biol 123(6 Pt 1): 1309-1320.
Russell, D., Snyder, S.H. (1968). Amine synthesis in rapidly growing tissues: ornithine
decarboxylase activity in regenerating rat liver, chick embryo, and various tumors.
Proc Natl Acad Sci USA 60(4): 1420-1427.
Russell, D.H. (1971). Increased polyamine concentrations in the urine of human cancer
patients. Nature New Biol 233(39): 144-145.
Räsänen, T., Alhonen, L., Sinervirta, R., Keinänen, T., Herzig, K., Suppola, S., Khomutov,
A.  R.  Vepsäläinen,  J.,  Jänne,  J.  (2002).  A  polyamine  analogue  prevents  acute
pancreatitis and restores early liver regeneration in transgenic rats with activated
polyamine catabolism. J Biol Chem 277(42): 39867-39872.
Räsänen, T. L., Alhonen, L., Sinervirta, R., Uimari, A., Kaasinen, K., Keinänen, T., Herzig,
K. H., Jänne, J. (2003). Gossypol activates pancreatic polyamine catabolism in
normal rats and induces acute pancreatitis in transgenic rats over-expressing
spermidine/spermine N1-acetyltransferase. Scand J Gastroenterol 38(7): 787-793.
Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., Arnheim, N.
(1985). Enzymatic amplification of beta-globin genomic sequences and restriction
site analysis for diagnosis of sickle cell anemia. Science 230(4732): 1350-1354.
Schroth, G.P., Chou, P.J., Ho, P.S. (1992). Mapping Z-DNA in the human genome.
67
Computer-aided mapping reveals a nonrandom distribution of potential Z-DNA-
forming sequences in human genes. J Biol Chem 267(17): 11846-11855.
Seiler, N. (1995). Polyamine oxidase, properties and functions. Prog Brain Res 106: 333-344.
Seiler, N. (2004). Catabolism of polyamines. Amino Acids 26(3): 217-33.
Seiler, N., Delcros, J.G., Moulinoux, J.P. (1996). Polyamine transport in mammalian cells.
An update. Int J Biochem Cell B 28(8): 843-861.
Semsei, I., Rao, G., Richardson, A. (1989). Changes in the expression of superoxide
dismutase and catalase as a function of age and dietary restriction. Biochem Biophys
Res Commun 164(2): 620-625.
Sequeira, A., Gwadry, F. G., Ffrench-Mullen, J. M. H., Canetti, L., Gingras, Y., Casero, R.
A.,  Rouleau,  G.,  Benkelfat,  C.,  Turecki,  G.  (2006).  Implication  of  SSAT  by  gene
expression and genetic variation in suicide and major depression. Arch Gen
Psychiatry 63(1): 35-48.
Shantz, L.M., Feith, D.J., Pegg, A.E. (2001). Targeted overexpression of ornithine
decarboxylase enhances beta-adrenergic agonist-induced cardiac hypertrophy.
Biochem J 358(Pt 1): 25-32.
Shantz, L.M., Pegg, A.E. (1994). Overproduction of ornithine decarboxylase caused by
relief of translational repression is associated with neoplastic transformation. Cancer
Res 54(9): 2313-2316.
Shantz, L.M., Viswanath, R., Pegg, A.E. (1994). Role of the 5'-untranslated region of
mRNA in the synthesis of S-adenosylmethionine decarboxylase and its regulation
by spermine. Biochem J 302 ( Pt 3): 765-772.
Shantz, L.M., Pegg, A.E. (1999). Translational regulation of ornithine decarboxylase and
other enzymes of the polyamine pathway. Int J Biochem Cell Biol 31(1): 107?122.
She, Q.B., Nagao, I., Hayakawa, T., Tsuge, H. (1994). A simple HPLC method for the
determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues:
the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem
Biophysl Res Commun 205(3): 1748-1754.
Shiba, T., Mizote, H., Kaneko, T., Nakajima, T., Kakimoto, Y. (1971). Hypusine, a new
amino acid occurring in bovine brain. Isolation and structural determination.
Biochim Biophys Acta 244(3): 523-531.
Smirnov, I.V., Dimitrov, S.I., Makarov, V.L. (1988). Polyamine-DNA interactions.
Condensation of chromatin and naked DNA. J Biomol Struct Dyn 5(5): 1149-1161.
Soulet, D., Gagnon, B., Rivest, S., Audette, M., Poulin, R. (2004). A fluorescent probe of
polyamine transport accumulates into intracellular acidic vesicles via a two-step
mechanism. J Biol Chem 279(47): 49355-49366.
Stanley, B.A., Pegg, A.E., Holm, I. (1989). Site of pyruvate formation and processing of
mammalian S-adenosylmethionine decarboxylase proenzyme. J  Biol  Chem 264(35):
21073-21079.
Straub, S.G., Sharp, G.W.G. (2002). Glucose-stimulated signaling pathways in biphasic
insulin secretion. Diabetes Metab Res Rev 18(6): 451-463.
Strømgaard, K., Jensen, L.S., Vogensen, S.B. (2005). Polyamine toxins: development of
selective ligands for ionotropic receptors. Toxicon 45(3): 249-254.
Suppola, S., Pietilä, M., Parkkinen, J. J., Korhonen, V. P., Alhonen, L., Halmekytö, M.,
Porter,  C.  W.,  Jänne,  J.  (1999).  Overexpression  of  spermidine/spermine  N1-
68
acetyltransferase  under  the  control  of  mouse  metallothionein  I  promoter  in
transgenic mice: evidence for a striking post-transcriptional regulation of transgene
expression by a polyamine analogue. Biochem J 338 ( Pt 2): 311-6.
Thomas,  T.,  Thomas,  T.J.  (1994).  Regulation  of  cyclin  B1  by  estradiol  and polyamines  in
MCF-7 breast cancer cells. Cancer Res 54(4): 1077-1084.
Thomas,  T.J.,  Bloomfield,  V.A.,  Canellakis,  Z.N.  (1985).  Differential  effects  on  the  B-to-Z
transition of poly(dG-me5dC).poly(dG-me5dC) produced by N1- and N8-acetyl
spermidine. Biopolymers 24(4): 725-729.
Tsuji, M., Nakajima, T., Sano, I. (1975). Putrescine, spermidine, N-acetylspermidine and
spermine in the urine of patients with leukaemias and tumors. Clin Chim Acta 59(2):
161-167.
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X.,
Soron, G., Cooper, B., Brayton, C., Hee Park, S., Thompson, T., Karsenty, G., Bradley,
A., Donehower, L.A. (2002). p53 mutant mice that display early ageing-associated
phenotypes. Nature 415(6867): 45-53.
Uemura, T., Yerushalmi, H. F., Tsaprailis, G., Stringer, D. E., Pastorian, K. E., Hawel, L.,
Byus, C. V., Gerner, E.W. (2008). Identification and characterization of a diamine
exporter in colon epithelial cells. J Biol Chem 283(39): 26428-26435.
Vega,  R.B.,  Huss,  J.M.,  Kelly,  D.P.  (2000).  The  coactivator  PGC-1  cooperates  with
peroxisome proliferator-activated receptor alpha in transcriptional control of
nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol
20(5): 1868-1876.
Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L., Porter, C.W. (2002a). Identification
and characterization of a novel flavin-containing spermine oxidase of mammalian
cell origin. Biochem J 367(Pt 3): 665?675.
Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L., Porter, C.W. (2002b). Identification
and characterization of a novel flavin-containing spermine oxidase of mammalian
cell origin. Biochem J 367(Pt 3): 665-675.
Wallace, H.M., Fraser, A.V. (2003a). Polyamine analogues as anticancer drugs. Biochem Soc
T 31(2): 393-6.
Wallace, H.M., Fraser, A.V., Hughes, A. (2003b). A perspective of polyamine metabolism.
Biochem J 376(Pt 1): 1-14.
Wang, H., Gauthier, B.R., Hagenfeldt-Johansson, K.A., Iezzi, M., Wollheim, C.B. (2002).
Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism-secretion
coupling of glucose-induced insulin release. J Biol Chem 277(20): 17564-17570.
Wang, Y., Devereux, W., Stewart, T.M., Casero, R.A. (2001a). Characterization of the
interaction between the transcription factors human polyamine modulated factor
(PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the
spermidine/spermine N1-acetyltransferase (SSAT) gene. Biochem J 355(Pt 1): 45-49.
Wang, Y., Devereux, W., Woster, P.M., Steward, T.M, Hacker, A., Casero, R.A. (2001b).
Cloning  and  characterization  of  a  human  polyamine  oxidase  that  is  inducible  by
polyamine analogue exposure. Cancer Res 61(14): 5370-5373.
Wang, Y., Xiao, L., Thiagalingam, A., Nelkin, B.D., Casero, R.A. (1998). The identification
of a cis-element and a trans-acting factor involved in the response to polyamines
and polyamine analogues in the regulation of the human spermidine/spermine N1-
69
acetyltransferase gene transcription. J Biol Chem 273(51): 34623-34630.
Wang, Y., Murray-Stewart, T., Devereux, W., Hacker, A., Frydman, B., Woster, P. M.,
Casero, R.A. (2003). Properties of purified recombinant human polyamine oxidase,
PAOh1/SMO. Biochem Biophys Res Commun 304(4): 605-611.
Welsh, N. )1990=. A role for polyamines in glucose-stimulated insulin-gene expression.
Biochem J 271(2): 393-397.
White, W.H., Gunyuzlu, P.L., Toyn, J.H. (2001). Saccharomyces cerevisiae is capable of de
novo pantothenic acid biosynthesis involving a novel pathway of beta-alanine
production from spermine. J Biol Chem 276(14): 10794-10800.
Wild, S.,  Roglic,  G.,  Green, A.,  Sicree,  R.,  King, H. (2004).  Global prevalence of diabetes:
estimates for the year 2000 and projections for 2030. Diabetes Care 27(5): 1047-1053.
Williams, K. (1997). Interactions of polyamines with ion channels. Biochem J 325 ( Pt 2):
289-297.
Williams-Ashman, H.G., Coppoc, G.L., and Weber, G. (1972). Imbalance in ornithine
metabolism  in  hepatomas  of  different  growth  rates  as  expressed  in  formation  of
putrescine, spermidine, and spermine. Cancer Res 32(9): 1924-1932.
Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J.M., Stoffel, M. (2004). Foxa2 regulates
lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature
432(7020): 1027-1032.
Wolfrum,  C.,  Besser,  D.,  Luca,  E.,  Stoffel,  M.  (2003).  Insulin  regulates  the  activity  of
forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation
and nuclear/cytosolic localization. Proc Natl Acad Sci USA 100(20): 11624-11629.
Xie, X., Gillies, R.J., Gerner, E.W. (1997). Characterization of a diamine exporter in
Chinese hamster ovary cells and identification of specific polyamine substrates. J
Biol Chem 272(33): 20484-20489.
Yerlikaya, A., Stanley, B.A. (2004). S-adenosylmethionine decarboxylase degradation by
the 26 S proteasome is accelerated by substrate-mediated transamination. J Biol
Chem 279(13): 12469?12478.
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford,
J., Kahn, C.R., Granner, D.K., Newgard, C.B., Spiegelman, B.M. (2001). Control of
hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature
413(6852): 131?8.
Zhang, L., Rubins, N.E., Ahima, R.S., Greenbaum, L.E., Kaestner, K.H. (2005). Foxa2
integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2(2):
141-148.
Zhang, M., Caragine, T., Wang, H., Cohen, P. S., Botchkina, G., Soda, K., Bianchi, M.,
Ulrich, P., Cerami, A., Sherry, B., Tracey, K.J. (1997). Spermine inhibits
proinflammatory cytokine synthesis in human mononuclear cells: a
counterregulatory mechanism that restrains the immune response. J Exp Med
185(10): 1759-1768.
Zhu,  C.,  Lang,  D.W.,  Coffino,  P.  (1999).  Antizyme2  is  a  negative  regulator  of  ornithine
decarboxylase and polyamine transport. J Biol Chem 274(37): 26425-26430.
Zuk,  D.,  Jacobson,  A.  (1998).  A  single  amino  acid  substitution  in  yeast  eIF-5A results  in
mRNA stabilization. EMBO J 17(10): 2914-2925.
Publications of the University of Eastern Finland
Dissertations in Health Sciences
isbn 978-952-61-0193-4
Publications of the University of Eastern Finland
Dissertations in Health Sciences
Although polyamines were originally 
discovered during the XVIIth century, 
their importance for the organism 
is still not completely understood. 
The use of molecules that resemble 
polyamines in their structure and 
function, i.e. polyamine analogues, 
and transgenic mice are the most 
used tools for the study of polyamines 
and their metabolism. The original 
techniques used for the analysis of 
polyamine functions and metabolism 
present limitations. Therefore, the 
development of new techniques to be 
used in the polyamine metabolism 
research could provide the necessary 
tools to advance our knowledge in this 
field.
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